1. Introduction {#sec1-materials-13-02670}
===============

Dental pulp-capping agents are defined as those materials used as a protective layer to an exposed tooth pulp to allow the tissue to recover and maintain its normal function and vitality \[[@B1-materials-13-02670],[@B2-materials-13-02670]\]. Ideally, those materials should not only be inert, in the sense that they should not be toxic to the pulp cells, but they should be "bioactive" towards the tissues by stimulating migration, proliferation and osteogenic differentiation of the cells \[[@B3-materials-13-02670],[@B4-materials-13-02670]\].

The tenets of minimal-invasive dentistry have caused a paradigm shift in the treatment of deep caries and vital pulp therapies. In this way, from total caries-excavation techniques, we have moved onto partial caries-excavation to avoid pulp exposures \[[@B5-materials-13-02670],[@B6-materials-13-02670],[@B7-materials-13-02670],[@B8-materials-13-02670]\]. Something similar is happening in the treatment of reversible and irreversible pulpitis. Increasing evidence is showing that in the presence of strict aseptic conditions (rubber dam isolation) and with the aid of magnification, partial or full pulpotomy can serve as valid and less invasive alternatives to root-canal treatment \[[@B8-materials-13-02670],[@B9-materials-13-02670],[@B10-materials-13-02670],[@B11-materials-13-02670]\]. This might have many advantages, since root-canal treatment is a more technically demanding and time-consuming treatment than (partial) pulpotomy \[[@B12-materials-13-02670]\].

Since the introduction of Pro-Root MTA (MTA; Dentsply-Sirona, Konstanz, Germany), the first hydraulic calcium-silicate cement developed, many other materials with similar compositions have been introduced into the market \[[@B13-materials-13-02670],[@B14-materials-13-02670],[@B15-materials-13-02670]\]. The main reasons for the increase of marketed materials are the good results obtained with MTA in terms of biocompatibility and long-term survival \[[@B16-materials-13-02670],[@B17-materials-13-02670]\], and the need for materials with improved handling properties, lesser discoloration risks, better sealing abilities and reduced prices \[[@B18-materials-13-02670],[@B19-materials-13-02670]\]. The latest developments in this search for improved dental pulp-capping agents are the resin-based calcium-silicate cements \[[@B20-materials-13-02670],[@B21-materials-13-02670],[@B22-materials-13-02670]\]. These materials possess enhanced handling properties by setting on command; they reduce the risk of discoloration; and, by optimizing the monomer composition, they may also adhere to tooth structure, by which improved sealing capacity can be expected \[[@B23-materials-13-02670],[@B24-materials-13-02670],[@B25-materials-13-02670]\]. Moreover, by adding resins to their composition, we may also better adhere them to resin composites and resin-modified glass ionomers, being put on top; reduce the treatment time; and reduce the risks of leakage and early filling loss \[[@B26-materials-13-02670]\]. However, the main drawback of this type of cement is the lack of biocompatibility of the monomers in contact with vital pulp tissue, which may hamper the formation of a complete hard tissue barrier at the exposed area \[[@B27-materials-13-02670],[@B28-materials-13-02670],[@B29-materials-13-02670]\]. Nevertheless, resins are not toxic by definition and many researchers are already working to develop biocompatible, naturally derived resin blends that may be suitable for biomedical applications \[[@B30-materials-13-02670],[@B31-materials-13-02670],[@B32-materials-13-02670],[@B33-materials-13-02670],[@B34-materials-13-02670]\]. These new type of photocurable resins are only prototypes but they have already been tested in in vitro and in vivo studies with promising results \[[@B35-materials-13-02670],[@B36-materials-13-02670],[@B37-materials-13-02670]\].

The *Guide to Clinical Endodontics* from the *American Association of Endodontists* recommends pulpotomy in permanent teeth only as an emergency or interim procedure until further root-canal treatment can be accomplished. However, recent randomized clinical trials have challenged this concept, as pulpotomy might be a successful treatment option for teeth with symptomatic irreversible pulpitis, even in cases with periapical involvement \[[@B11-materials-13-02670],[@B38-materials-13-02670],[@B39-materials-13-02670],[@B40-materials-13-02670],[@B41-materials-13-02670],[@B42-materials-13-02670]\]. As this type of treatment is becoming more scientifically supported, a recent review and position statement article from the *European Society for Endodontology* \[[@B8-materials-13-02670]\] opened the door for this paradigm shift and clinicians are starting to perform such treatments \[[@B43-materials-13-02670],[@B44-materials-13-02670],[@B45-materials-13-02670]\]. In this way, the best available evidence suggests that the materials of choice for vital pulp therapy are calcium-hydroxide or MTA \[[@B46-materials-13-02670]\]. However, these materials have many side effects. The main problem of calcium hydroxide is its high solubility, which will create a gap between pulp tissue and final restorative material \[[@B47-materials-13-02670]\]. For MTA, the main drawbacks are: (1) risk of discoloration, (2) long-setting time and (3) difficult handling \[[@B19-materials-13-02670]\]. Therefore, recently introduced materials are gaining popularity among clinicians; for example, tricalcium-silicate cements such as Biodentine (Septodont, Saint-Maur-des-Fossés, France), and resin-based calcium-silicate cements, such as Theracal LC (Bisco, Schaumburg, IL, USA) and Biocal Cap (Harvard, Hoppegarten, Germany). However, very limited information is available regarding their biocompatibility when they are exposed to human dental pulp cells and tissue.

Recently, many reviews have been written about dental pulp-capping therapies and materials \[[@B48-materials-13-02670],[@B49-materials-13-02670],[@B50-materials-13-02670],[@B51-materials-13-02670]\]. However, concerningly, this is the first systematic review aiming to compare all kinds of pulp-capping agents, including resin-based materials. Moreover, by using an indirect meta-analytical approach, we have tried to shed some light on the controversy that some studies found no difference in terms of (long-term) survival and reparative bridge formation between calcium-hydroxide materials and calcium-silicate cements \[[@B46-materials-13-02670],[@B52-materials-13-02670],[@B53-materials-13-02670]\], while others showed that calcium-silicate cements improved the prognosis of vital-pulp therapies \[[@B49-materials-13-02670],[@B50-materials-13-02670]\].

Therefore, the aim of this study was to assess the in vitro biocompatibility of dental pulp-capping materials for vital pulp therapy when exposed to human dental pulp cells. As a secondary objective, in vivo studies were reviewed for inflammatory reaction and the presence of reparative dentin formation after direct exposure of the pulp tissue of completely developed permanent teeth to pulp-capping materials.

The null-hypotheses tested were (1) that there is no difference in in vitro biocompatibility for the different pulp-capping agents when exposed to human dental pulp cells; (2) that there is no difference in the short-term (\<30 days) inflammatory reaction caused by the materials tested in vivo; and (3) that there is no difference in complete hard-tissue bridge formation in vivo after 30 days among the different materials tested.

2. Material and Methods {#sec2-materials-13-02670}
=======================

2.1. Protocol and Registration {#sec2dot1-materials-13-02670}
------------------------------

The methodology of this review was based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines \[[@B54-materials-13-02670],[@B55-materials-13-02670]\]. This review was registered at the PROSPERO database (number: CRD42020164374).

The protocol for this review was designed by the authors with the support of an expert librarian from the Biomedical Sciences group of KU Leuven.

2.2. Eligibility Criteria {#sec2dot2-materials-13-02670}
-------------------------

The eligibility criteria were different depending on the type of study (i.e., in vitro vs. in vivo studies) and the specific characteristics (inclusion and exclusion criteria) for each type of study are shown in [Table 1](#materials-13-02670-t001){ref-type="table"}.

2.3. Information Sources {#sec2dot3-materials-13-02670}
------------------------

A literature search was performed using the *PubMed*, *EMBASE* and *Web of Science* databases ([Figures S1--S3](#app1-materials-13-02670){ref-type="app"}). The first search was performed on 1 October 2019 and was updated for the last time on 1 May 2020. No filters were applied. After removing duplicates with Endnote X9 software (Clarivate Analytics), we chose studies starting from 1993, because it is the date when mineral trioxide aggregate was patented, and together with calcium hydroxide it is considered as gold-standard material for pulp-preserving procedures. Finally, a manual search was conducted from the reference lists of relevant review articles published in the last 5 years.

2.4. Search Strategy {#sec2dot4-materials-13-02670}
--------------------

The search strategy was designed by 2 reviewers (MSP and XL) in collaboration with an expert librarian. As the main purpose of the review was not to find a specific answer to a specific clinical question, we decided to conduct the literature search using the main terms of interest, instead of the classic PICO structure. The main terms of interest chosen were: (1) "*Biocompatibility or pulp-tissue reaction*"; (2) "*Pulp-capping materials or agents*"; and, (3) *"(Human) dental pulp cells/tissue or (human) teeth."* The complete search strategy used in the *PubMed*, *EMBASE* and *Web of Science* databases can be found in the [Supplementary Information (Figures S1--S3)](#app1-materials-13-02670){ref-type="app"}.

2.5. Study Selection and Data Collection Process {#sec2dot5-materials-13-02670}
------------------------------------------------

Studies were selected and data collected by two independent investigators (MSP and XL) who revised the full list of articles and selected the papers that were potentially of interest, first by title and then by abstract screening. Later, texts were fully screened to identify the articles that met the inclusion criteria. In case of disagreement, differences were discussed until agreement was reached. Only articles published in the English language were chosen ([Figure 1](#materials-13-02670-f001){ref-type="fig"}).

Data extraction was done separately for in vitro ([Table 2](#materials-13-02670-t002){ref-type="table"}) and in vivo studies ([Table 3](#materials-13-02670-t003){ref-type="table"} and [Table 4](#materials-13-02670-t004){ref-type="table"}). For the in vitro studies, the following data were obtained from the selected articles: (1) study characteristics: authors and year of publication, (2) materials tested, (3) type of exposure (direct/indirect) and the use of fresh or set materials, (4) parameters tested, (5) methods used and (6) results obtained. For the in vivo studies, the data collected were the following: (1) study characteristics: authors and year of publication, (2) type of study: randomized controlled trial (RCT) or controlled clinical trial (CCT), (3) method used for hemostasia, (4) materials tested, (5) etching of pulp tissue, (6) evaluation time, (7) presence (or not) of an independent examiner of the histological samples, (8) characteristics of the bridge formed, (9) characteristics of the inflammatory reaction and (10) amount and type of teeth used and age of the patients. When the data from the articles were unclear or could not be found, we contacted the authors by e-mail or ResearchGate. If no answer was received, the articles were excluded.

2.6. Risk of Bias in Individual Studies {#sec2dot6-materials-13-02670}
---------------------------------------

For the risk of bias of in vivo studies and for the meta-analysis, the *Cochrane Handbook for Systematic Reviews of Interventions 6* \[[@B109-materials-13-02670]\] and the *Review Manager 5.3* software \[[@B110-materials-13-02670]\] provided by the Cochrane collaboration ([www.cochrane.org](www.cochrane.org)) were followed. The risk of bias of each individual study can be found next to each forest plot in the meta-analysis ([Figure 2](#materials-13-02670-f002){ref-type="fig"}, [Figure 3](#materials-13-02670-f003){ref-type="fig"}, [Figure 4](#materials-13-02670-f004){ref-type="fig"} and [Figure 5](#materials-13-02670-f005){ref-type="fig"}).

2.7. Data Analysis {#sec2dot7-materials-13-02670}
------------------

### 2.7.1. Data Synthesis {#sec2dot7dot1-materials-13-02670}

For the in vivo studies, quantitative analysis was performed with Review Manager 5.3 (Revman) software provided by the Cochrane Collaboration ([www.cochrane.org](www.cochrane.org)). Dichotomous data were presented in forest plots as odds ratios (OR) with 95% confidence intervals (CIs) ([Figure 2](#materials-13-02670-f002){ref-type="fig"}, [Figure 3](#materials-13-02670-f003){ref-type="fig"}, [Figure 4](#materials-13-02670-f004){ref-type="fig"} and [Figure 5](#materials-13-02670-f005){ref-type="fig"}). When the heterogeneity of the studies was considered "*low*" (I^2^ \< 50%), "*fixed effects*" were considered. When heterogeneity was "*high*" or when it was not possible to measure (no direct comparisons available), "*random effects*" were evaluated. The difference in the effect between different materials was considered statistically significant when *p* \< 0.05. Instead of the "*odds ratio*," the "*relative risk*" (RR) was presented in [Table 5](#materials-13-02670-t005){ref-type="table"}, [Table 6](#materials-13-02670-t006){ref-type="table"}, [Table 7](#materials-13-02670-t007){ref-type="table"} and [Table 8](#materials-13-02670-t008){ref-type="table"} for the sake of simplicity in the interpretation of the results \[[@B109-materials-13-02670]\].

### 2.7.2. Heterogeneity Assessment {#sec2dot7dot2-materials-13-02670}

The chi-square test and I^2^ statistic were used to assess heterogeneity. The fixed-effect model is suitable to estimate the typical effect for studies with low heterogeneity (I^2^ \< 50%), whereas the random-effects model is used to assess the average distribution for studies with substantial unexplained heterogeneity (I^2^ ≥ 50% or *p* ≤ 0.05) \[[@B109-materials-13-02670]\].

### 2.7.3. Assessment of Publication Bias {#sec2dot7dot3-materials-13-02670}

If more than 10 articles were included, publication bias was analysed by visual inspection of funnel plots. An asymmetrical distribution of funnel plot data may suggest the possibility of publication bias \[[@B109-materials-13-02670]\].

### 2.7.4. Summary Measures {#sec2dot7dot4-materials-13-02670}

For the parameter "*inflammation*" of the included in vivo studies, inflammation was noted only when it was scored as severe or when the pulp tissue was defined as necrotic or abscess formation (severe inflammation and/or necrosis/abscess formation were considered as "*event*" in the Revman 3.5 software). As the parameter "*inflammation*" is dynamic (it might change over time), it was evaluated separately for different time points (i.e., inflammation up to 7 days, at day 15 and at day 30). Periods longer than 30 days were not taken into account, as inflammation due to material toxicity occurs normally within a short-day range. Inflammation occurring at longer time periods may be due to bacterial infiltration or trauma.

To evaluate the parameter "*bridge formation*" of the included in vivo studies, only the presence of a complete bridge was taken into account. When the bridge was incomplete or not present, this was considered as an "*event*" in the Revman 3.5 software.

The results were expressed as the *odds ratios* and 95% CIs (the "*relative risk*" (RR) was presented in [Table 5](#materials-13-02670-t005){ref-type="table"}, [Table 6](#materials-13-02670-t006){ref-type="table"}, [Table 7](#materials-13-02670-t007){ref-type="table"} and [Table 8](#materials-13-02670-t008){ref-type="table"} for the sake of simplicity in the interpretation of the results). When possible, heterogeneity of the studies and bias publication were also recorded. As many materials have been tested over time and no direct comparison was always available between them, an indirect meta-analysis was performed. Moreover, a network meta-analysis graph was made for all the available studies and their respective interactions ([Figure 6](#materials-13-02670-f006){ref-type="fig"}).

2.8. Statistical Analysis {#sec2dot8-materials-13-02670}
-------------------------

We conducted a meta-analysis to obtain estimates of the relative effectiveness of all interventions on the primary outcome by combining direct and indirect evidence using a fixed-effects or random-effects model.

2.9. Risk of Bias Across Studies (Certainty in the Evidence) {#sec2dot9-materials-13-02670}
------------------------------------------------------------

The quality of the evidence was assessed using the "*Grading of Recommendations Assessment, Development and Evaluation*" (GRADE) approach at the outcome level for each comparison between interventions \[[@B111-materials-13-02670]\]. The certainty in the evidence can be high, moderate, low or very low. When the certainty is derived from direct comparisons, randomized controlled trials provide high-certainty evidence. However, some issuese such as serious risk of bias, imprecision, inconsistency or publication bias can reduce the certainty \[[@B111-materials-13-02670]\].

3. Results {#sec3-materials-13-02670}
==========

3.1. Search Results and Study Selection {#sec3dot1-materials-13-02670}
---------------------------------------

The PRISMA flowchart with the search results and the study selection process can be seen in [Figure 1](#materials-13-02670-f001){ref-type="fig"}. The *PubMed*, *EMBASE* and *Web of Science* searchs provided 6490, 4369 and 5682 results, respectively. The total sum of 16,541 articles was stored in a reference manager (Endnote X9, Clarivate Analytics). Twelve results found by hand searching through the reference lists of the articles and from other sources were added. Duplicates were removed manually with Endnote X9 (Clarivate Anaytics) reference manager, resulting in 10,469 unique articles. From these 10,469 studies, 1536 were excluded because they were published before 1993 (date of the first publication on MTA \[[@B15-materials-13-02670]\]). From the remaining 8933 articles, 7628 and 1117 articles were excluded as being non-relevant by screening the titles and abstracts, respectively. Finally, 188 articles were eligible for full-text screening ([Figure 1](#materials-13-02670-f001){ref-type="fig"}). The year of publication ranged from 1946 to 2020 (later reduced to 1993--2020). The selection process is detailed in the PRISMA flow chart ([Figure 1](#materials-13-02670-f001){ref-type="fig"}). Two in vivo studies that met de inclusion criteria were finally not included (after contacting the authors) in the qualitative/quantitative analysis because the data had been partially used in previous studies ([Figure 1](#materials-13-02670-f001){ref-type="fig"}) \[[@B112-materials-13-02670],[@B113-materials-13-02670]\]. Finally, 56 articles were included in the analysis, 26 involving in vitro studies and 30 in vivo studies. The reasons for exclusion are listed in [Figure 1](#materials-13-02670-f001){ref-type="fig"} and a full list of excluded articles (with reason for exclusion) is provided in [Supplementary Table S1 (Table S1)](#app1-materials-13-02670){ref-type="app"}. Moreover, these 30 in vivo studies were included for quantitative meta-analysis, among which there were 10 controlled clinical trials (CCT) and 20 randomized controlled trials (RCT). The sample sizes of these studies were n = 355 (premolars) for immature permanent teeth and n = 657 for mature permanent teeth (301 molars and 356 premolars) for a total of 1012 teeth in all 30 included in vivo studies.

3.2. Study Characteristics {#sec3dot2-materials-13-02670}
--------------------------

The characteristics of the included in vitro and in vivo studies are listed in [Table 2](#materials-13-02670-t002){ref-type="table"}, [Table 3](#materials-13-02670-t003){ref-type="table"} and [Table 4](#materials-13-02670-t004){ref-type="table"}. The in vivo studies were subdivided depending on whether they included mature or immature permanent teeth ([Table 3](#materials-13-02670-t003){ref-type="table"} and [Table 4](#materials-13-02670-t004){ref-type="table"}, respectively).

### Risk of Bias within Studies

The risk of bias of the in vivo studies is presented along with the meta-analysis (forest plots; [Figure 2](#materials-13-02670-f002){ref-type="fig"}, [Figure 3](#materials-13-02670-f003){ref-type="fig"}, [Figure 4](#materials-13-02670-f004){ref-type="fig"} and [Figure 5](#materials-13-02670-f005){ref-type="fig"}) and was determined following the Cochrane recommendations using the software Revman 5.3 (Cochrane). In general, except for two studies \[[@B85-materials-13-02670],[@B100-materials-13-02670]\], most of the included in vivo studies were deemed as having high risk of bias. The most frequent types of bias were *selection and performance biases*, as in most studies no "*random sequence generation*" nor "*allocation concealment*" were described. It is true that "*blinding of participants and personnel*" is difficult to achieve as the materials have different appearances. Therefore, when this was the only risk of bias present, we did not consider it a high bias risk. However, this was the case in only two out of 30 studies.

3.3. Synthesis of Results {#sec3dot3-materials-13-02670}
-------------------------

The results for each individual in vitro and in vivo study are presented in [Table 2](#materials-13-02670-t002){ref-type="table"}, [Table 3](#materials-13-02670-t003){ref-type="table"} and [Table 4](#materials-13-02670-t004){ref-type="table"}, respectively. For the in vivo studies, a quantitative meta-analytical analysis was performed when possible ([Table 5](#materials-13-02670-t005){ref-type="table"}, [Table 6](#materials-13-02670-t006){ref-type="table"}, [Table 7](#materials-13-02670-t007){ref-type="table"} and [Table 8](#materials-13-02670-t008){ref-type="table"}). By preference, the meta-analysis was conducted using studies where direct comparison was evaluated. However, when direct comparison was not available (or not enough), an indirect evaluation was performed. The two parameters quantitatively analysed in vivo were: (1) occurrence of severe inflammation (or necrosis/abscess formation) in the pulp tissue up to a period of 30 days ([Table 5](#materials-13-02670-t005){ref-type="table"}, [Table 6](#materials-13-02670-t006){ref-type="table"} and [Table 7](#materials-13-02670-t007){ref-type="table"}), and (2) formation of a complete bridge between the material and the pulp tissue after 30 or more days ([Table 8](#materials-13-02670-t008){ref-type="table"}).

### 3.3.1. Qualitative Analysis of In Vitro Studies {#sec3dot3dot1-materials-13-02670}

The qualitative analysis of the included in vitro studies showed that the materials that were studied the most in contact with human dental pulp cells of primary origin were the hydraulic calcium-silicate cements (hCSCs), Pro-Root MTA (Dentsply-Sirona; 9/26 studies) and Biodentine (Septodont; 7/26 articles) ([Table 2](#materials-13-02670-t002){ref-type="table"}). These were followed by MTA-Angelus (Angelus, Londrina, Brazil; 5/26 studies), the calcium-hydroxide (CH) cement Dycal (Dentsply-Sirona, Konstanz, Germany; 5/26 studies), the resin-free hCSC iRoot BP (Innovative Bioceramix; 4/26 studies), the resin-based calcium-silicate cement (Rb-CSC) Theracal LC (Bisco; 4/26 studies) and Portland cement (Ssangyong, Seoul, Korea; 4/26 studies). The other included materials were tested in three or less studies ([Table 2](#materials-13-02670-t002){ref-type="table"}). From the analysis, in general hCSCs (Pro-Root MTA, Dentsply-Sirona; Biodentine, Septodont; MTA-Angelus, Angelus; iRoot BP, Innovative Bioceramix; Portland cement, Ssangyong) were found to be non-cytotoxic when in (in)direct contact with human dental pulp cells, while they also exhibited bioactivity (migration, proliferation, mineralization capacities) towards human tooth pulp cells they were exposed to \[[@B28-materials-13-02670],[@B59-materials-13-02670],[@B61-materials-13-02670],[@B62-materials-13-02670],[@B63-materials-13-02670],[@B65-materials-13-02670],[@B66-materials-13-02670],[@B67-materials-13-02670],[@B68-materials-13-02670],[@B70-materials-13-02670],[@B74-materials-13-02670],[@B77-materials-13-02670],[@B80-materials-13-02670]\]. Moreover, the CH cement Dycal (Dentsply-Sirona) was in general deemed cytotoxic (in some studies cytotoxicity could not be tested because most of the cells died in contact with this calcium-hydroxide cement), and when directly compared, Dycal (Dentsply-Sirona) was more cytotoxic than the hCSCs tested \[[@B58-materials-13-02670],[@B59-materials-13-02670],[@B66-materials-13-02670],[@B80-materials-13-02670]\]. The Rb-CSC Theracal LC (Bisco) seemed not to be as cytotoxic as Dycal (Dentsply-Sirona) \[[@B69-materials-13-02670]\], but when compared to hCSCs, contradictory results were reported as some authors showed similar results with both materials \[[@B70-materials-13-02670]\], while other authors showed more cytotoxicity and less bioactivity with Theracal LC (Bisco) \[[@B28-materials-13-02670],[@B62-materials-13-02670]\].

### 3.3.2. Meta-Analysis of the Effect of Pulp-Capping Agents on the Inflammatory Reaction Induced in Human Pulp Tissue {#sec3dot3dot2-materials-13-02670}

#### Inflammatory Reaction at Day 30

The inflammatory reaction induced by the different materials at day 30 is shown in [Table 5](#materials-13-02670-t005){ref-type="table"}. No significant difference was found in any of the direct or indirect comparisons/combinations tested. However, the quality/certainty of the evidence was very low or low following the GRADE recommendations. This was mostly due to the lack of studies directly comparing materials or the few studies available.

The materials that were tested the most were Pro-Root MTA (Dentsply-Sirona) and CH powder/saline---11 and eight studies, respectively. For these two materials, severe inflammation or necrosis/abscess formation were not reported in any of the included studies. Other studies investigated CH cements, such as Dycal (Dentsply-Sirona) or Life (Kerr, Orange, CA, USA); other MTA-like products, such as MTA-Angelus (Angelus); and resin-based adhesives.

#### Inflammatory Reaction at Day 15

The inflammation induced by the different materials at day 15 is shown in [Table 6](#materials-13-02670-t006){ref-type="table"}. No significant difference was found in any of the direct or indirect comparisons/combinations tested. However, not many studies were found in this time-period category and therefore not many comparisons could be included. In this case, the quality/certainty of the evidence was very low or low following the GRADE recommendations. This is mostly due to the lack of studies directly comparing materials or the few studies available.

#### Inflammatory Reaction up to Day 7

The inflammatory reaction induced by the different materials at day 7 is shown in [Table 7](#materials-13-02670-t007){ref-type="table"}. No significant difference was found in any of the direct or indirect comparisons/combinations tested. However, the quality/certainty of the evidence was very low or low following the GRADE recommendations. Likewise, as explained above for the 15 and 30-day periods, this must mostly be attributed to the lack of studies directly comparing materials or the few studies available.

#### Meta-Analysis of the Effect of Pulp-Capping Materials on Hard-Tissue Formation upon Capping Exposed Human Pulp Tissue

The ability of the each pulp-capping agent to induce dentin-bridge formation is shown in [Table 8](#materials-13-02670-t008){ref-type="table"}. Some comparisons between materials did reveal significant differences ([Table 8](#materials-13-02670-t008){ref-type="table"}). The most frequently tested materials were: (1) resin-free MTA-like cements within 14 studies \[12 studies tested Pro-Root MTA (Dentsply-Sirona) and two studies Angelus-MTA (Angelus)\], (2) calcium-hydroxide cements within 13 studies \[nine studies tested Dycal (Dentsply-Sirona), three studies Life (Kerr), one study Calcimed (Cerkamed, Stalowa Wola, Poland) and one study Multi-Cal Liner (Pulpdent, Watertown, MA, USA)\], (3) pure calcium-hydroxide powder/saline paste within 12 studies and (4) resin-based adhesives within 11 studies \[three studies tested Scotchbond Multipurpose (3M, Seefeld, Germany), three studies Clearfil SE Bond (Kuraray Noritake, Tokyo, Japan), three studies Clearfil Liner Bond 2 (Kuraray Noritake, Tokyo, Japan), one study Single Bond (3M, Seefeld, Germany), one study Single Bond Universal (3M, Seefeld, Germany), one study All-Bond 2 (Bisco) and one study Prime&Bond NT 2.1 (Dentsply-Sirona, Konstanz, Germany)\]. To have a better overview of how frequently the different capping agents were tested and their interactions, a graphic network analysis is shown in [Figure 6](#materials-13-02670-f006){ref-type="fig"}.

The materials that more often induced dentin-bridge formation were calcium-hydroxide powder/saline and Pro-Root MTA (Dentsply-Sirona). Unfortunately, the two cements were not directly compared and the reported results originate from indirect comparisons ([Table 8](#materials-13-02670-t008){ref-type="table"}). However, when both materials were indirectly compared ([Table 8](#materials-13-02670-t008){ref-type="table"}), no significant difference in dentin-bridge formation was found (Relative risk (95% CI) = 1.64 (0.98, 2.77)), although the difference was statistically borderline non-significant in favour of calcium-hydroxide powder/saline (*p* = 0.06) ([Figure 2](#materials-13-02670-f002){ref-type="fig"}). The quality/certainty of the evidence was ranked as moderate, since the data were gathered from many different studies conducted by many different authors ([Table 8](#materials-13-02670-t008){ref-type="table"} and [Figure 2](#materials-13-02670-f002){ref-type="fig"}). When MTA-Angelus (Angelus) was also taken into account, the difference between the materials was significant in favour of calcium-hydroxide powder/saline (relative risk (95% CI) = 2.24 (1.19, 4.20; *p* = 0.007); one study that directly compared materials was then included \[[@B52-materials-13-02670]\] ([Table 8](#materials-13-02670-t008){ref-type="table"}).

On the other hand, calcium-hydroxide cements, such as Dycal (Dentsply-Sirona) and Life (Kerr), performed significantly worse than calcium-hydroxide powder/saline (Relative risk (95% CI) = 3.23 (2.00, 5.20), *p* \< 0.00001) and MTA-like cements (relative risk (95% CI) = 0.41 (0.23, 0.73), *p* \< 0.0001) ([Figure 3](#materials-13-02670-f003){ref-type="fig"} and [Figure 4](#materials-13-02670-f004){ref-type="fig"}, respectively).

When calcium-hydroxide cements were indirectly compared to hydraulic calcium-silicate cements (hCSCs), such as Biodentine (Septodont) and iRoot BP (Innovative Bioceramix, Vancouver, Canada), no significant difference was found in favour of hCSCs (relative risk (95% CI) = 0.47 (0.15, 1.44), *p* = 0.12) ([Table 8](#materials-13-02670-t008){ref-type="table"}). The difference was significant in favour of hCSC (*p* \< 0.001) when the materials were directly compared. However, we found only one study where these two materials were directly compared, because of which this finding should be taken with caution \[[@B107-materials-13-02670]\]. The quality of evidence varied among the different comparisons from high (MTA-like materials vs. calcium-hydroxide (CH) cements), to moderate (CH cements vs. CH powder/saline) to low (hCSCs vs. CH cements) depending on the amount and quality of studies available.

Furthermore, the comparison between resin-based vs. resin-free materials was significantly different in favour of the resin-free materials (relative risk (95% CI) = 3.69 (2.23, 6.12), *p* \< 0.0001) ([Table 8](#materials-13-02670-t008){ref-type="table"} and [Figure 5](#materials-13-02670-f005){ref-type="fig"}). The result was significantly different independently of which resin-free material was used (CH powder, CH cements, resin-free MTA-like cements or resin-free hCSCs).

3.4. Risk of Bias Across Studies {#sec3dot4-materials-13-02670}
--------------------------------

The risk of bias across studies (interpreted as the certainty of quality of evidence) was analysed using the GRADE recommendation. For most of the comparisons done between material categories for the parameter "Inflammatory reaction," the certainty/quality in evidence was mostly evaluated as "very low" or "low." This must mostly be ascribed to high risk of bias in individual studies but also to the few articles present in most categories increasing the imprecision and inaccuracy levels ([Table 5](#materials-13-02670-t005){ref-type="table"}, [Table 6](#materials-13-02670-t006){ref-type="table"} and [Table 7](#materials-13-02670-t007){ref-type="table"}).

For the parameter "reparative bridge formation," after pulp capping with different materials, most comparisons were categorized as of "moderate" or "high" quality. In this case, the number of articles that directly compared materials was higher than for the "inflammation" parameter. Moreover, the total number of cases available was also high, reducing the total imprecision and inaccuracy levels ([Table 8](#materials-13-02670-t008){ref-type="table"}).

4. Discussion {#sec4-materials-13-02670}
=============

4.1. Summary of Results {#sec4dot1-materials-13-02670}
-----------------------

The results of this systematic review showed that cell viability and bioactivity of the pulp-capping materials exposed to human dental pulp cells in vitro differ among the materials tested ([Table 2](#materials-13-02670-t002){ref-type="table"}). Therefore, the first null-hypothesis that there is no difference among the materials tested, was rejected.

Moreover, the outcomes of the meta-analysis regarding in vivo inflammatory effect of the different pulp-capping agents did not reveal differences among the materials tested ([Table 5](#materials-13-02670-t005){ref-type="table"}, [Table 6](#materials-13-02670-t006){ref-type="table"} and [Table 7](#materials-13-02670-t007){ref-type="table"}). Therefore, we failed to reject the second null-hypothesis.

In vivo, the formation of a complete hard-tissue bridge in healthy human teeth after exposure and subsequent pulp capping varied as a function of the materials used ([Table 8](#materials-13-02670-t008){ref-type="table"}). In this way, the third null-hypothesis that there is no difference in hard-tissue formation among the materials tested, was also rejected.

The main conditions for a successful vital pulp therapy are: (1) a healthy patient with a good healing capacity, (2) a pulp-tissue environment free of bacteria and (3) a biocompatible material \[[@B45-materials-13-02670],[@B114-materials-13-02670],[@B115-materials-13-02670],[@B116-materials-13-02670]\]. Of these three characteristics, we were interested in studying the effect of biocompatibility of the different pulp-capping materials on human pulp tissue. However, biocompatibility is a broad term requiring both in vitro and in vivo tests to be conducted. This is the reason why we included studies evaluating cytotoxicity and bioactivity of materials by exposing human pulp tissue in vitro and in vivo to these materials. There are also many studies evaluating biocompatibility towards pulp tissue in animals. However, it has been shown that there might be differences in reaction of pulp tissue from animals as compared to humans due to different metabolisms and immune system responses \[[@B117-materials-13-02670],[@B118-materials-13-02670]\]. Therefore, because of the relatively high availability of human studies, we decided to include only studies performed on human dental pulp cells or human teeth.

The main reason for failure after vital pulp therapy is (re)infection of pulp tissue by bacteria \[[@B9-materials-13-02670],[@B10-materials-13-02670],[@B45-materials-13-02670],[@B116-materials-13-02670],[@B119-materials-13-02670]\]. Therefore, in order to selectively evaluate the effectiveness of different pulp-capping agents, we included only studies that performed vital pulp therapy on sound teeth from healthy volunteers using a strict aseptic environment (i.e., rubber dam isolation). By doing so, we intended to avoid cofounding factors like environmental contamination or lack of healing capacity of patients.

### 4.1.1. Systematic Review of In Vitro Studies {#sec4dot1dot1-materials-13-02670}

The systematic review of the included in vitro studies showed that not much research has been done evaluating the direct effect of dental adhesives and resin composites on human dental pulp cells. Only two out of 26 studies (one for adhesives \[[@B28-materials-13-02670]\] and one for resin composites \[[@B78-materials-13-02670]\]) ([Table 2](#materials-13-02670-t002){ref-type="table"}) met the inclusion criteria ([Table 1](#materials-13-02670-t001){ref-type="table"}). The reason for this might be that the dental scientific community \[based mostly on the results from in vitro studies and histology involving animal and human teeth ([Table 3](#materials-13-02670-t003){ref-type="table"}, [Table 4](#materials-13-02670-t004){ref-type="table"} and [Table 5](#materials-13-02670-t005){ref-type="table"})\] has accepted that resins and monomers eluted from adhesives and composites are toxic for pulp cells \[[@B29-materials-13-02670],[@B81-materials-13-02670],[@B83-materials-13-02670],[@B84-materials-13-02670],[@B86-materials-13-02670],[@B92-materials-13-02670],[@B93-materials-13-02670],[@B97-materials-13-02670],[@B98-materials-13-02670],[@B105-materials-13-02670],[@B120-materials-13-02670],[@B121-materials-13-02670],[@B122-materials-13-02670],[@B123-materials-13-02670],[@B124-materials-13-02670],[@B125-materials-13-02670]\]. However, this is in contradiction with the desire and increasing tendency from industry and researchers to develop resin-based pulp-capping materials, which are more user and patient friendly. Some examples of this kind of material are the resin-based calcium-hydroxide cements Prisma VLC (Dentsply-Sirona), Calcimol (Voco, Cuxhave, Germany) and Lime-Lite (Dentsply-Sirona), and the resin-modified calcium-silicate materials Theracal LC (Bisco) and Biocal Cap (Harvard).

It is difficult to make much out of the results of in vitro studies because most of them each use a different method to prepare the materials or to expose the cells. Moreover, not all of them refer to the ISO-standards (only 10/26 studies explicitly mentioned the use of ISO-standards) and the ISO-standards have been changing over time. This is important because if the data cannot be compared, the results are difficult to interpret and extrapolate. Furthermore, companies and researchers have to adhere to ISO-standards to develop/evaluate their materials. If the experiments are not done following these recommendations, the results might be less applicable.

Another particular issue with research involving hCSCs is that most researchers used "set" materials to conduct their experiments (only 2/26 included in vitro studies used "freshly-mixed" cements in their experimental protocol; [Table 2](#materials-13-02670-t002){ref-type="table"}) \[[@B66-materials-13-02670],[@B76-materials-13-02670]\]. On the one hand, a protocol involving "set" materials is very useful, as it allows an easier set-up and more standardization of the experiments. However, care should be taken when designing the protocols, as hCSCs are very sensitive to drought (they need water to set and achieve their physio-mechanical properties), and, more importantly, in the clinic they are brought into contact with the pulp tissue when they are still setting ("freshly mixed"). Therefore, the use of "freshly-mixed" cements has a benefit in the case of these pulp-capping agents.

### 4.1.2. Systematic Review and Meta-Analysis of In Vivo Studies {#sec4dot1dot2-materials-13-02670}

#### Inflammatory Reaction

From the analysis of the inflammatory reactions of human pulp tissue exposed to the biomaterials tested, we may conclude that there exists no difference in inflammatory reaction induced by the materials tested ([Table 5](#materials-13-02670-t005){ref-type="table"}, [Table 6](#materials-13-02670-t006){ref-type="table"} and [Table 7](#materials-13-02670-t007){ref-type="table"}). However, we have to be cautious because evaluating inflammatory reaction can be very subjective. This is the reason why we decided to count as "*events*" only very strong inflammatory reactions, such as severe inflammation or necrosis/abscess formation. Even though in most of studies an independent examiner was selected to avoid risk of bias, the difference between slight and moderate inflammatory reaction is very subjective. Severe inflammation or necrosis are in principle more objective outcomes. We should also bear in mind that hard-tissue histology, particularly tooth histology, is a difficult technique, even for pathologists (as they are not often confronted with hard tissues such as teeth). Much methodological experience is needed before quality sections can be prepared and trustable information gathered. It may happen that artefacts caused by incorrect fixation or induced during demineralization and cutting procedures are confused with pulp-tissue damage. Moreover, in most studies a limited number of sections are obtained. This is not ideal, as pulp tissue may appear normal in one part but inflamed in another part. Therefore, it is recommended that the whole pulp tissue is cut and sections from different areas are stained and analysed to guarantee representativeness \[[@B126-materials-13-02670]\].

#### Complete Reparative Bridge Formation

For the in vivo quantitative analysis, different comparisons were conducted. Comparison between resin-based and resin-free materials clearly elicited that the latter produce more frequently complete dentin bridges than the former (*p* \< 0.001; [Table 8](#materials-13-02670-t008){ref-type="table"} and [Figure 5](#materials-13-02670-f005){ref-type="fig"}). Comparison of Pro-Root MTA (Dentsply-Sirona) with calcium hydroxide (CH) yielded contradictory results. When we analysed studies comparing pure CH powder with Pro-Root MTA (Dentsply-Sirona), pure CH powder produced more frequently complete bridges than Pro-Root MTA (Dentsply-Sirona), although no statistically significant difference was recorded (*p* = 0.06; odds ratio (95% CI) = 1.85 (0.98, 3.49)) ([Figure 2](#materials-13-02670-f002){ref-type="fig"}). However, when we evaluated studies comparing CH cements, such as Dycal (Dentsply-Sirona) vs. Pro-Root MTA (Dentsply-Sirona), a significant difference in the formation of complete bridges was found in favour of MTA (*p* \< 0.01; [Table 8](#materials-13-02670-t008){ref-type="table"} and [Figure 3](#materials-13-02670-f003){ref-type="fig"}). This is relevant, especially in places were the high cost and/or lack of a national insurance system make it difficult for clinicians and patients to afford materials like Biodentine (Septodont) or Pro-Root MTA (Dentsply-Sirona). Moreover, many researchers and clinicians consider CH cements, such as Dycal (Dentsply-Sirona) and Life (Kerr), to be the same as or similar to as pure CH powder, and therefore, as *gold-standard* materials for vital pulp therapy \[[@B69-materials-13-02670]\]. This has led to many clinical trials evaluating pulp-capping treatment with CH cements serving as control ("gold-standard") materials, with disastrous results \[[@B7-materials-13-02670],[@B16-materials-13-02670],[@B17-materials-13-02670],[@B127-materials-13-02670],[@B128-materials-13-02670]\]. Therefore, as previous research had already highlighted, and considering the results of this meta-analysis, pure CH powder and CH cements should not be considered to be the same \[[@B52-materials-13-02670],[@B129-materials-13-02670],[@B130-materials-13-02670]\]. Even though the quantity/quality of mineral bridge formation seems higher when using resin-free hCSCs \[[@B131-materials-13-02670]\], pure CH powder is a very cheap alternative with excellent efficiency for vital pulp therapy. Its efficacy has been backed up with almost 100 years of scientific evidence behind it, including in vitro, ex vivo and in vivo studies on animal and human teeth \[[@B126-materials-13-02670],[@B132-materials-13-02670],[@B133-materials-13-02670],[@B134-materials-13-02670]\].

4.2. Comparison with Previous Studies and Limitations {#sec4dot2-materials-13-02670}
-----------------------------------------------------

Recently, there have been many review articles about this topic \[[@B48-materials-13-02670],[@B49-materials-13-02670],[@B50-materials-13-02670],[@B51-materials-13-02670],[@B135-materials-13-02670]\]. However, some limitations of these reviews were that, (1) they focused on the comparison between CH compounds and MTA \[[@B50-materials-13-02670]\]; (2) they only included in their analyses studies with a direct comparison between the materials tested \[[@B48-materials-13-02670],[@B49-materials-13-02670]\] or (3) they only compared in vitro articles \[[@B51-materials-13-02670],[@B135-materials-13-02670]\]. In our systematic review, we wanted to go further, and we included all types of pulp-capping materials and, both in vitro and in vivo studies. Moreover, we also did an indirect comparison between the different materials tested, similarly to a network meta-analysis \[[@B136-materials-13-02670]\]. By doing so, we were able to include a comparison between pure CH powder and Pro-root MTA (Dentsply-Sirona), as there has been, to our knowledge, no research performed in human teeth comparing both materials directly \[[@B112-materials-13-02670],[@B137-materials-13-02670]\].

Some of the limitations of this study are the narrow scope of the review by including only in vitro studies performed on human dental pulp cells from primary sources and in vivo studies performed on healthy permanent human teeth using strict aseptic criteria. However, we think that there have been other recent reviews studying the effect of these type of materials on other cell lines (i.e., human dental (stem) cells from the apical papilla (SCAPs) or (stem) cells from human exfoliated deciduous teeth (SHEDs)) and also using animal cell lines/tissue or teeth \[[@B48-materials-13-02670],[@B135-materials-13-02670]\]. Other limitations may be the limited timespan of the review, as we took into consideration only articles from 1993, and the short-term follow-up of the in vivo studies. Regarding the timespan of the review, we did so because the first hydraulic calcium-silicate cement (Pro-Root MTA, Dentsply-Sirona) was developed in 1993 and the first article was published in 1995. Moreover, the use of human dental pulp cells of primary origin became popular from the year 2000 and on, after publication that stem cells could be harvested from human teeth \[[@B138-materials-13-02670],[@B139-materials-13-02670],[@B140-materials-13-02670]\]. In relation to the short-term follow-up of the in vivo studies, we wanted to evaluate the histological characteristics of the inflammatory reaction and the reparative bridge formation after exposure with different pulp-capping agents. In the long-term, other factors like the health status of the patient or the quality of the coronal restoration play important roles. Therefore, in order to exclude or minimize these co-founding factors, we wanted to focus solely in the (short-term) histological features of the healing after pulp-capping. However, care should be taken when interpreting the results of this systematic review and meta-analysis, as some articles studying the effects of dental materials on human cells or teeth might have been left aside for those reasons.

5. Conclusions and Recommendations for Future Research {#sec5-materials-13-02670}
======================================================

In conclusion, we want to stress that materials such as pure calcium-hydroxide (CH) powder and Pro-Root MTA (Dentsply-Sirona) have shown excellent biocompatibility in vitro and in vivo when tested on human cells and teeth. Their use after many years of research and clinical experience seems safe and proven for vital pulp therapy in healthy individuals given that an aseptic environment (rubber dam isolation) is maintained. More recently introduced hCSCs like Biodentine (Septodont) and iRoot BP (Innovative Bioceramix) showed promising results, but more studies are necessary to confirm their suitability. However, in general, all these hCSCs have many disadvantages, such as long setting times, lack of bonding capacity to tooth structures, high solubility and high risk of discoloration, which make them difficult to handle and less user and patient friendly.

Newer, setting-on-command materials, such as resin-based calcium-silicate cements, are therefore highly desirable. Nevertheless, before these innovative materials can be used in patients, improved bioactivity and biocompatibility are needed and mandatory. Moreover, for these materials to be successful in the clinical practice, better bonding capacity to hard dental tissues and enhanced physio-mechanical properties are also needed. On the one hand, by having a strong bonding ability to dentin, better sealing ability and reduced long-term bacterial leakage is expected. On the other hand, increased physio-mechanical properties may ensure that these materials can be used also as definitive restorations. We highly encourage clinicians not to use new materials in patients until sufficient scientific evidence has been provided. Even minor changes in composition may have drastic consequences in the clinical outcomes of our treatments.
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![Forest plot and risk of bias of the studies evaluating the formation of a complete reparative bridge comparing calcium-hydroxide powder (CH powder) with Pro-Root MTA (Dentsply-Sirona) (odds ratio (95% CI), random effects). An "*event*" was considered the lack of a complete hard bridge after 30 days of pulp-capping.](materials-13-02670-g002){#materials-13-02670-f002}

![Forest plot and risk of bias of the studies directly comparing the formation of a complete reparative bridge when calcium-hydroxide (CH) cements or CH powder/saline paste were used (odds ratio (95% CI), random effects). An "*event*" was considered the lack of a complete hard bridge after 30 days of pulp-capping.](materials-13-02670-g003){#materials-13-02670-f003}

![Forest plot and risk of bias of the studies directly comparing Pro-Root MTA (Dentsply-Sirona) to calcium-hydroxide cements (CH cements) for the formation of a complete reparative (odds ratio (95% CI), fixed effects). An "*event*" was considered the lack of a complete hard bridge after 30 days of pulp-capping.](materials-13-02670-g004){#materials-13-02670-f004}

![Forest plot and risk of bias of the studies directly comparing the formation of a complete reparative bridge with resin-based and resin-free materials (including pure calcium hydroxide powder, calcium hydroxide cements and hydraulic Calcium-Silicate cements) (odds ratio (95% CI), random effects). An "*event*" was considered the lack of a complete hard bridge after 30 days of pulp-capping.](materials-13-02670-g005){#materials-13-02670-f005}

![Schematic representation (network) of the interaction among the in vivo studies (n = 30). The balls (nodes) represent the materials and the times each material was studied. The line thickness and the number connected to the lines (edges), linking two materials, represent the frequency of interactions between them.](materials-13-02670-g006){#materials-13-02670-f006}

materials-13-02670-t001_Table 1

###### 

Eligibility criteria for in vitro and in vivo studies.

  ----------------------------------------------- ------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------
  **Eligibility criteria for in vitro studies**                                                                

  **Characteristics**                             **Inclusion Criteria**                                       **Exclusion Criteria**

  Publication year                                Studies published from 1993                                  Studies published before 1993

  Language                                        English                                                      Other languages different than English

  Population                                      Human dental pulp cells from a primary source\               Other type of oral/dental cells or cells not from primary source (i.e.,: immortalized cells, commercial cell lines, ...)\
                                                  Cells from more than 1 patient                               Cells obtained from one single patient

  Tests performed                                 At least 2 different tests were performed                    Only 1 test was performed (i.e.,: cytotoxicity, mineralization ability, \...)

  Materials tested                                Commercially available materials\                            Experimental materials or modification of an existing material\
                                                  Resin-based or resin-free pulp-capping materials             Materials for other purposes (sealers, fixation cements, monomers, ...)

  Analysis                                        At least 2 different materials compared between each other   Materials compared only to the control

  **Eligibility criteria for in vivo studies**                                                                 

  Publication year                                Studies published from 1993                                  Studies published before 1993

  Language                                        English                                                      Other languages different than English

  Ethical Committee                               Mentioned                                                    No ethical committee mentioned in the text

  Population                                      Permanent teeth\                                             Primary teeth\
                                                  Healthy teeth (free from caries or infection)\               Teeth exhibiting caries or periodontal disease\
                                                  Patients' age and amount of teeth should be provided         Sample size and age of the participants not mentioned

  Materials tested                                Commercially available materials\                            Experimental materials or modification of an existing material\
                                                  Resin-based or resin-free pulp-capping materials\            Materials for other purposes (sealers, fixation cements, monomers, ...)\
                                                  Clear description and brand of the materials used            No clear description and brand of the materials used

  Analysis                                        Histology\                                                   Studies where "only" clinical parameters were evaluated\
                                                  Inflammation and hard-tissue formation                       No bridge formation evaluated

  Type of study                                   Randomized or controlled clinical trials (RCT or CCT)        Other type of studies (case reports, case series, ...)
  ----------------------------------------------- ------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------

materials-13-02670-t002_Table 2

###### 

Included in vitro studies. Symbols of greater than (\>), less than (\<) or equal to (=) are used to compare the results of the tested groups.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------- ----------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Studies**                                                                                                                                                                                                                                                                                                                                                                                     **Materials**                                                                                                                                                                     **Type of Exposure**                                                                                                                                                                                                                                                                                                                                                                                                              **Parameters**                          **Methods**                                           **Results**

  Alliot-Licht\                                                                                                                                                                                                                                                                                                                                                                                   Calcium hydroxide (CH)\                                                                                                                                                           CH particles sterilized by heating (180 °C-1 h); direct contact\                                                                                                                                                                                                                                                                                                                                                                  Cell morphology                         Light microscopy (at 3 & 5 days)                      CH inhibited pulp fibroblasts growth (\<cell density than control; subjective observation)\
  et al.\                                                                                                                                                                                                                                                                                                                                                                                         Hydroxyapatite (HAp)                                                                                                                                                              (materials powder in culture medium)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            HAp did not affect the cell density (≈cell density as the control; subjective observation)
  (1994) \[[@B56-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Phagocytotic activity                                                                                                                                                                                                                                                                                                                                                                           SEM (at day 5)                                                                                                                                                                    Close contact of CH particles with fibroblasts' membrane. HAp particles were closely bound to cell membrane or internalized by the cells.                                                                                                                                                                                                                                                                                                                                                                                       

  TEM (at day 5)                                                                                                                                                                                                                                                                                                                                                                                  Cells cultured in the presence of CH exhibited ghost cells and electron-dense spherical vesicles in the cytoplasm of living cells. TEM revealed HAp particles within the cells.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Cell proliferation                                                                                                                                                                                                                                                                                                                                                                              DNA synthesis (at 1, 2, 3 & 4 days)                                                                                                                                               CH and HAp delayed the proliferation of cells at all time points.                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Protein synthetic activity (at 6 days)                                                                                                                                                                                                                                                                                                                                                          CH \< incorporation of \[^3^H\]-leucine and \[^3^H\]-proline by pulp fibroblasts at day 6.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                  HAp \> incorporation of \[^3^H\]-leucine and \[^3^H\]-proline by the pulp fibroblasts at day 6.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            ALP activity (at 8 days for CH; at 5 & 8 days for HAp)                                                                                                                            CH inhibited ALP activity of pulp fibroblasts at day 8.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    HAp inhibited ALP activity of pulp fibroblasts at 5 and 8 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Min et al. (2007) \[[@B57-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                                 Portland cement (PC)\                                                                                                                                                             Indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                                 Cell viability                          MTT assay (at 12, 24, 48 & 72 h)                      PC \> BPC at 12 and 24 h\
                                                                                                                                                                                                                                                                                                                                                                                                  Portland cement with bismuth oxide (BPC)                                                                                                                                          (SET materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 PC ≈ BPC at 48 and 72 h

  Nitric oxide production                                                                                                                                                                                                                                                                                                                                                                         Griess reaction(at 12, 24, 48 & 72 h)                                                                                                                                             BPC \> nitrite production than PC at 12 and 24 h.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    PC ≈ BPC nitrite production at 48 and 72 h.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Ho-1 and iNOS                                                                                                                                                                                                                                                                                                                                                                                   RT-PCR (at 12, 24, 48 & 72 h)                                                                                                                                                     Ho-1: PC \< BPC at all study periods\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    iNOS: PC \< BPC at all study points                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Min et al. (2007) \[[@B58-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                                 Portland cement (PC) Fuji-II LC (Fuji-II, GC)\                                                                                                                                    Direct and indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                      Cell morphology                         SEM (at 24 h)                                         PC: showed flattened cells close to one another and spreading across the substrate.\
                                                                                                                                                                                                                                                                                                                                                                                                  Zinc-oxide Eugenol (IRM; Dentsply-Sirona)\                                                                                                                                        (SET materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Fuji-II, IRM, and Dycal: no living cells were seen.
                                                                                                                                                                                                                                                                                                                                                                                                  CH cement Dycal (Dentsply-Sirona)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Cell viability                                                                                                                                                                                                                                                                                                                                                                                  MTT assay (at 12, 24, 48 & 72 h)                                                                                                                                                  PC ≈ control at all study periods.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    PC \> Fuji-II, Dycal and IRM at all study periods.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Control \> Fuji II LC, IRM, and Dycal at all study points.                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            RT-PCR (ON, DSPP) (at 7 days)                                                                                                                                                     ON: PC ≈ positive control group.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    DSPP: PC stimulated mineralization but less than the positive control.                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Laurent\                                                                                                                                                                                                                                                                                                                                                                                        Ca~3~SiO~5~ cement (CS)\                                                                                                                                                          Indirect contact \*\                                                                                                                                                                                                                                                                                                                                                                                                              Cell viability                          MTT assay (at 24 h)                                   No contact (disk diffusion): CS ≈ MTA ≈ Dyc\
  et al. (2008) \[[@B59-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                                     Dycal (Dentsply-Sirona)\                                                                                                                                                          (SET materials)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Indirect contact (eluates from materials): Cs ≈ MTA \> Dycal
                                                                                                                                                                                                                                                                                                                                                                                                  Pro-Root MTA (MTA; Dentsply-Sirona)                                                                                                                                               \[ISO-Standard--(Nr. Not mentioned)\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            Immunohistochemistry (at 4 weeks)                                                                                                                                                 MTA and CS expressed Nestin and Collagen I at a similar level as the control group. Both materials generated mineral deposits at a similar level as the control group.                                                                                                                                                                                                                                                                                                                                                          

  Genotoxicity                                                                                                                                                                                                                                                                                                                                                                                    Ames test                                                                                                                                                                         CS does not induce reverse mutations with/without the S9 metabolic activation system.                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Micronuclei test\                                                                                                                                                                                                                                                                                                                                                                               CS generated lymphocytes with micronuclei ≈ as the negative control.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Comet assay                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  CS generated DNA in the tail ≈ as the negative control and \< than the cytotoxic control.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Min et al. (2009) \[[@B60-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                                 Radiopaque Portland cement (RPC)\                                                                                                                                                 Direct and indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                      Cell morphology                         SEM (at 48 h)                                         PC and RPC: Spread and flattened HDPCs. The density and characteristics of the HDPCs in both groups were similar to that on control samples.\
                                                                                                                                                                                                                                                                                                                                                                                                  Portland cement (PC) IRM (Dentsply-Sirona)                                                                                                                                        (SET materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 IRM: no living cells were seen in contact with the

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            ALP activity\                                                                                                                                                                     1d: PC and RPC \> control; 3d, 7d, 14d: control \> PC and RPC\                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                  (at 1, 3, 7 & 14 days)                                                                                                                                                            2wk and 3wk: PC and PCR \> control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    DSPP: PC and RPC \> control at day 14; OCN: control ≈ Pc and RPC at all study periods.                                                                                                                                                                                                                                                                                                                                                                                                                                          

  ARS staining (1, 2 & 3 wk)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  RT-PCR (DSPP, ON)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  (at 1, 3, 7 & 14 days)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Lee et al. (2014) \[[@B61-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                                 ProRoot MTA (MTA; Dentsply-Sirona)\                                                                                                                                               Direct and indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                      Cell morphology                         SEM (at 72 h)                                         hDPCs in contact with MTA and α-TCP were well-spread and flattened.
                                                                                                                                                                                                                                                                                                                                                                                                  α-tricalcium phosphate-based cement (α-TCP)                                                                                                                                       (SET materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Cell viability                                                                                                                                                                                                                                                                                                                                                                                  MTT assay (at 1, 2, 3, 7 & 14 days)                                                                                                                                               MTA and α-TCP ≈ control until day 7\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    α-TCP \> MTA at 14d; α-TCP ≈ control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            Western blot (DSPP, DMP-1 and ON) (at 3 days)                                                                                                                                     α-TCP ≈ MTA for DSPP, DMP-1 and ON.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  ARS staining (at 14 days)                                                                                                                                                                                                                                                                                                                                                                       α-TCP ≈ MTA for DSPP, DMP-1 and ON.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Immunofluorescence (DSPP, DMP-1 and ON) (at 7 days)                                                                                                                                                                                                                                                                                                                                             α-TCP and MTA induced higher protein signals than the control group.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Bortoluzzi et al. (2015) \[[@B62-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                          Biodentine (Bd; Septodont)\                                                                                                                                                       Indirect contact \*\                                                                                                                                                                                                                                                                                                                                                                                                              Cell viability                          XTT assay (direct and indirect eluate evaluations)\   Direct evaluation:\
                                                                                                                                                                                                                                                                                                                                                                                                  Theracal LC (Th; Bisco)\                                                                                                                                                          (SET materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                           Flow cytometry--\                                     1st cycle: control \> Bd \> MTA-A and Th\
                                                                                                                                                                                                                                                                                                                                                                                                  MTA Angelus (MTA-A; Angelus)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Annexin V-PI\                                         2nd cycle: control \> Bd ≈ MTA-A \> Th\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              (4 weekly cycles)                                     3rd cycle: control ≥ MTA-A ≥ Bd \> Th\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    4th cycle: control ≈ Bd ≈ MTA-A \> Th\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Indirect eluate evaluation:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1:1&1:10 dilutions: control \> MTA-A ≈ Bd \> Th; 1:100 dilution: control ≈ MTA-A ≈ Bd \> Th\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Percentage of healthy, non-apoptotic and non-necrotic cells: control \> MTA-A ≈ Bd \> Th\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Th was the most cytotoxic material causing apoptosis and necrosis.

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            qRT-PCR (DSPP, OCN, BSP, RUNX 2, DMP-1 and ALP) (at 7 days)                                                                                                                       ALP; OCN; BSP; DSPP; DMP-1: Bd and MTA-A \> control ≈ Th\                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    RUNX 2: Bd ≈ MTA-A ≈ control ≈ Th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  ALP activity (at 14 days)                                                                                                                                                                                                                                                                                                                                                                       Bd ≈ control \> MTA-A \> Th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  ARS and TEM (at 21 days)                                                                                                                                                                                                                                                                                                                                                                        Bd \> control \> MTA-A \> Th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Niu et al.\                                                                                                                                                                                                                                                                                                                                                                                     ProRoot MTA (MTA; Dentsply-Sirona)\                                                                                                                                               Direct and indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                      Cell viability                          Flow cytometry--\                                     Number of healthy cells:\
  (2015) \[[@B63-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                                            Quick-Set2 (Qs; Avalon Biomed Inc)                                                                                                                                                (SET materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                           Annexin V-PI\                                         1st cycle: control \> Qs \> MTA (*p* \< 0.001) \> IRM\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              (3 weekly cycles)\                                    2nd cycle: control \> Qs ≈ MTA \> IRM; 3rd cycle: control ⩾ MTA ⩾ Qs \> IRM\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Leakage of cytosolic enzyme (3 weekly cycles)\        Percentage of cytotoxicity:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Caspase-3 acitivity (3 weekly cycles)\                1st cycle: IRM \> MTA \> Qs \> control; 2nd and 3rd cycles: IRM \> MTA ≈ Qs \> control\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Oxidative stress (3 weekly cycles)                    Relative caspase-3 activity:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1st cycle: IRM \> MTA \> Qs \> control; 2nd cycle: IRM \> MTA \> Qs \> control\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    3rd cycle: IRM \> MTA ≈ Qs \> control\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Oxidative stress:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1st cycle: IRM \> MTA \> Qs \> control; 2nd cycle: IRM \> MTA ≈ Qs \> control\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    3rd cycle: IRM \> MTA ≈ Qs ≈ control

  Cell proliferation                                                                                                                                                                                                                                                                                                                                                                              MTT assay (3 weekly cycles)Cellular DNA content (3 weekly cycles)                                                                                                                 1st cycle: control \> Qs \> MTA \> IRM\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    2nd cycle: control \> Qs ≈ MTA \> IRM\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    3rd cycle: control \> Qs \> MTA \> IRM\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    DNA content:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1st cycle: control \> Qs \> MTA \> IRM\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    2nd cycle: control \> Qs ≈ MTA \> IRM\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    3rd cycle: control \> Qs ≈ MTA \> IRM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Öncel Torun et al.\                                                                                                                                                                                                                                                                                                                                                                             iRoot BP Plus (iBP; Innovative Bioceramix)\                                                                                                                                       Indirect contact (SET materials)                                                                                                                                                                                                                                                                                                                                                                                                  Cell viability                          XTT assay\                                            24 h; 1:1 and 1:2 dilutions: iBP \> W-MTA-A; 1:5 and 1:10 dilutions: iBP ≈ MTA-A\
  (2015) \[[@B64-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                                            White MTA Angelus (MTA-A; Angelus)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          (24, 48 & 72 h)                                       48 h; 1:1 dilution: iBP \> W-MTA-A; 1:2, 1:5 and 1:10 dilutions: iBP ≈ MTA-A\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h; all concentrations: iBP ≈ MTA-A

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            qRT-PCR\                                                                                                                                                                          BMP-2:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                  (BMP-2, ON, BSP, OPN, DSPP, Col I A1, HO-1 at 24 & 72 h)                                                                                                                          24 h 1:1 and 1:5 dilutions MTA-A \> iBP; 1:2 dilution: iBP ≈ MTA-A\                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h 1:1, 1:2 and 1:5 dilutions MTA-A \> iBPON:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    24 h 1:1 and 1:5 dilutions iBP \> MTA-A; 1:2 diution: iBP ≈ MTA-A\                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h: 1:1 dilution iBP \> MTA-A; 1:2 and 1:5 dilutions MTA-A \> iBP BSP:\                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    24 h: 1:1 dilution MTA-A \> iBP; 1:2 and 1:5 diutions: iBP ≈ MTA-A\                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h: 1:1 and 1:2 dilutions MTA-A \> iBP; 1:5 diution: iBP ≈ MTA-AOPN:\                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    24 h: 1:2 dilution iBP \> MTA-A; 1:1 and 1:5 dilutions: iBP ≈ MTA-A\                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h: 1:1 and 1:5 dilutions MTA-A \> iBP; 1:2 dilution: iBP ≈ MTA-A\                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    DSPP:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    24 h: 1:1 dilution iBP \> MTA-A; 1:2 and 1:5 dilutions: iBP ≈ MTA-A\                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h: 1:2 dilution iBP\> MTA-A; 1:1 dilution MTA-A \> iBP; 1:5 dilution: iBP ≈ MTA-ACol I A1:\                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    24 h: 1:1 dilution iBP \> MTA-A; 1:2 and 1:5 dilutions: iBP ≈ MTA-A\                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h: 1:1 and 1:2 dilutions iBP \> MTA-A; 1:5 dilution: iBP ≈ MTA-AHO-1:\                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    24 h 1:1 and 1:2 dilutions MTA-A \> iBP; 1:5 dilution: iBP ≈ MTA-A\                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h: 1:1, 1:2 and 1:5 dilutions MTA-A \> iBP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Zhang et al.(2015) \[[@B65-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                                iRoot BP Plus (iBP; Innovative Bioceramix)\                                                                                                                                       Indirect contact (SET materials)\                                                                                                                                                                                                                                                                                                                                                                                                 Cell Viability                          Flow cytometry--\                                     iBP ≈ MTA ≈control
                                                                                                                                                                                                                                                                                                                                                                                                  ProRoot MTA (MTA; Dentsply-Sirona)                                                                                                                                                (ISO 10993-5)                                                                                                                                                                                                                                                                                                                                                                                                                                                             Annexin V-PI                                          

  Cell Migration                                                                                                                                                                                                                                                                                                                                                                                  Wound-healing at 24 h                                                                                                                                                             iBP ≈ MTA \> control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Transwell assay at 24 h                                                                                                                                                                                                                                                                                                                                                                         iBP = MTA \> control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Cellular adhesion and motility                                                                                                                                                                                                                                                                                                                                                                  Western-Blot\                                                                                                                                                                     iBP led to phosphorylation of p38 MAPK, ERK 1/2, JNK, Akt, and FGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                  (at 5, 10, 30 & 60 min)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                  Cell Immunofluorescence assay (at 1 h)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  iBP significantly increased p--focal adhesion kinase (p-FAK), p-paxillin, and vinculin\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Cells treated with iBP showed highly organized and stretched stress fiber assembly                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Chung CJ et al. (2016) \[[@B66-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                            Dycal (Dy; Dentsply-Sirona)\                                                                                                                                                      Indirect and direct contact;\                                                                                                                                                                                                                                                                                                                                                                                                     Cell morphology/attachment              Phase microscopy\                                     3d: MTA \> cell morphology and attachement than R-MTA and E-Zr\
                                                                                                                                                                                                                                                                                                                                                                                                  Endocem Zr (E-Zr, Maruchi)\                                                                                                                                                       SET (s) and FRESH (f) materials                                                                                                                                                                                                                                                                                                                                                                                                                                           (at 3 & 7 days)\                                      7d: MTA, R-MTA and E-Zr sowed good cell morphology and attachement\
                                                                                                                                                                                                                                                                                                                                                                                                  White ProRoot MTA (MTA; Dentsply-Sirona)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   SEM (at 3 & 7 days)                                   Dycal treated cells were dead after 3 and 7 days. Dycal was not further used
                                                                                                                                                                                                                                                                                                                                                                                                  Retro-MTA (R-MTA; Bio MTA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Cell viability                                                                                                                                                                                                                                                                                                                                                                                  XTT assay (at 3 & 7 days)                                                                                                                                                         3 d: control ≈ MTA (s) ≈ MTA (f) \> R-MTA (s) ≈ R-MTA (f) \> E-Zr (s) ≈ E-Zr (f)\                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    7 d: MTA(f) \> control ≈ MTA (s) ≈ R-MTA (s) ≈ R-MTA (f) ≈ E-Zr (f) \> E-Zr (s)                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Angiogenic properties                                                                                                                                                                                                                                                                                                                                                                           ELISA (VEGF, angiogenin, FGF-2) (at 3 & 7 days)                                                                                                                                   VEGF24 h: control ≈ MTA (s) ≈ R-MTA (s) ≈ R-MTA (f) ≥ MTA (f) ≈ E-Zr (s) \> E-Zr (f)\                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    VEGF72 h: MTA (s) ≈ MTA (f) ≈ R-MTA (s) ≈ E-Zr (s) ≥ control ≥ R-MTA (f) ≈ E-Zr (f)\                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Angiogenin 24 h: control≈ MTA(s) ≥ R-MTA (s) \> MTA(f) \> R-MTA (f) ≈ E-Zr(s)\>E-Zr (f)\                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Angiogenin 72 h: R-MTA (s) ≈ R-MTA (f) ≈ control \> MTA(s) ≈ MTA (f) \> E-Zr (s) ≈ E-Zr (f)\                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    FGF-2 24 h and 72 h: no difference among materials and control                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Daltoé M et al. (2016) \[[@B67-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                            Biodentine (Bd; Septodont)\                                                                                                                                                       Indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                                 Cell Viability                          MTT assay (at 24 & 48 h)                              24 h: control ≈ MTA_1:100 ≈ Bd_1:100 \> MTA_1:10, Bd_1:10, Bd_1:1 and MTA_1:1\
                                                                                                                                                                                                                                                                                                                                                                                                  White ProRoot MTA\                                                                                                                                                                (SET materials)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                48 h: control ≈ MTA_1:100 ≈ Bd_1:100 \> MTA_1:10, Bd_1:10, MTA_1:1 and Bd_1:1
                                                                                                                                                                                                                                                                                                                                                                                                  (MTA; Dentsply-Sirona)                                                                                                                                                            (ISO 10993-5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            qRT-PCR (SPP1, IBSP, DSPP, ALP 1, DMP-1 and RUNX 2 (at 24 & 48 h)                                                                                                                 SPP1 & ALP1 & RUNX2 at 24 h: Bd and MTA ≈ control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    SPP1 & ALP1 & RUNX2 48 h: Bd and MTA \> control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    IBSP & DSPP & DMP1: 24 h and 48 h: no expression                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Widbiller M et al. (2016) \[[@B68-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                         Biodentine (Bd; Septodont)\                                                                                                                                                       Indirect and direct contact\                                                                                                                                                                                                                                                                                                                                                                                                      Cell morphology/attachement (only Bd)   SEM (at 24 h)                                         Biodentine: cells showed adhesion to and spreading onto the cement surface\
                                                                                                                                                                                                                                                                                                                                                                                                  GI Ketac-Molar (KM; 3M)\                                                                                                                                                          (SET materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \* Not done for the other materials.
                                                                                                                                                                                                                                                                                                                                                                                                  ProRoot MTA (MTA; Dentsply-Sirona)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Cell viability                                                                                                                                                                                                                                                                                                                                                                                  MTT assay (at 1, 3, 5, 7, 10 & 14 days)                                                                                                                                           Bd \> other materials and control at 1, 3, 5 and 7 d;\                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Bd ≈ MTA \> control \> KM at 10 and 14 d\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    MTA \< viability than the control at 1d; MTA ≈ cell viability as the control at 3-5-7d;\                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    KM \< cell viability than all the materials tested and the control at all time points                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Cell differentiation\                                                                                                                                                                                                                                                                                                                                                                           RT-qPCR (ALP, Col-I A1, DSPP, RUNX 2) (at 7, 14 & 21 days)                                                                                                                        Col-I A1 & ALP: upregulated at 7d, especially for MTA, and decreased steadily until 21d\                                                                                                                                                                                                                                                                                                                                                                                                                                        
  Not performed on KM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               DSPP: upregulated for MTA and BD at 14 and 21d\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    RUNX2: downregulated for MTA and BF throughout the whole study period                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  ALP activity (at 3, 7 & 14 days)                                                                                                                                                                                                                                                                                                                                                                ALP activity was downregulated for Bd at all times: MTA ≈ control \> Bd                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Jeanneau C et al. (2017) \[[@B28-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                          Biodentine (Bd; Septodont)\                                                                                                                                                       Indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                                 Cell proliferation                      MTT assay (3, 5, & 7 days)                            Bd_0.05 cm^2^/mL \> Th\_ 0.05 cm^2^/mL (*p* \< 0.05) ≈ control at 3, 5 and 7 days\
                                                                                                                                                                                                                                                                                                                                                                                                  Theracal LC (Th; Bisco)\                                                                                                                                                          (SET materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Bd_0.5 cm^2^/mL \> Th\_ 0.5 cm^2^/mL (*p* \< 0.05) ≈ control at 3, 5 and 7 days
                                                                                                                                                                                                                                                                                                                                                                                                  Xeno III (Dentsply-Sirona)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            Immunofluorescence\                                                                                                                                                               Bd increased the expression of both markers, while Th had no effect                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                  (DSP and Nestin at day 7)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Inflammatory effect                                                                                                                                                                                                                                                                                                                                                                             ELISA (IL-8; 24 and 48 h)                                                                                                                                                         IL-8 expression at 24 h: Th_0.05 cm^2^/^mL^ \> Bd_0.05 cm^2^/^mL^ ≈ control\                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    IL-8 expression at 48 h: Th_0.05 cm^2^/^mL^ \> Bd_0.05 cm^2^/^mL^ \> control                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Jun S-K et al. (2017) \[[@B69-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                             Activa Bioactive (Activa; Pulpdent)\                                                                                                                                              Indirect contact (SET materials)\                                                                                                                                                                                                                                                                                                                                                                                                 Cell viability                          MTS assay (at 24 h)\                                  3.125% eluates: Dy \> Th \> Activa ≈ control; 6.25% eluates: Dy \> Th ≈ Activa ≈ control\
                                                                                                                                                                                                                                                                                                                                                                                                  Dycal (Dy; Dentsply-Sirona)\                                                                                                                                                      (ISO 10993-12)                                                                                                                                                                                                                                                                                                                                                                                                                                                            Live/dead assay (at 24 h)                             12.5% eluates: Dy ≈ Th ≈ Activa ≈ control; 25% eluates: Dy \< Activa \< Th \< control\
                                                                                                                                                                                                                                                                                                                                                                                                  Theracal LC (Th; Bisco)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           50% eluates: Dy ≈ Activa \< Th \< control\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    50% eluates: Dy \< Activa \< Th \< control

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            ALP (at days 14 and 21)                                                                                                                                                           14 d: Th \> Dy \> Activa ≈ Osteogenic medium\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    21 d: Th ≈ Dy \> Activa \> Osteogenic medium                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  ARS (at 21 days)                                                                                                                                                                                                                                                                                                                                                                                Th ≈ Dy \> Activa ≈ Osteogenic medium                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Lee B-N et al. (2017) \[[@B70-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                             ProRoot MTA (MTA; Dentsply-Sirona)\                                                                                                                                               Indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                                 Cell viability                          WST-1 assay (at 24 h)                                 100% concentration: Th \> MTA; At 50%, 25% and 10% dilutions: Th ≈ MTA\
                                                                                                                                                                                                                                                                                                                                                                                                  Theracal LC (Th; Bisco)                                                                                                                                                           (SET materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 At 100% MTA: cell viability \< 70% and significantly lower than Th.

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            RT-PCR (DSPP, DMP-1 at 1 & 3d)\                                                                                                                                                   DSPP 1 d: MTA \> Th ≈ control; 3 d: MTA ≈ Th \> control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                  Q-PCR(DSPP, DMP-1 at 2, 5 & 7d)\                                                                                                                                                  DMP-1 at 1 and 3d: MTA ≈ Th ≈ control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                  ALP staining (at day 7)\                                                                                                                                                          DSPP & DMP-1: upregulated for both materials, especially at day 7.\                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                  ARS (at day 14)                                                                                                                                                                   MTA \> Th ≈ control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    MTA \> Th \> control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Mestieri LB et al. (2017) \[[@B71-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                         White MTA Angelus (MTA-A; Angelus)\                                                                                                                                               Indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                                 Cell viability                          MTT assay                                             1:2, 1:3, 1:4 and 1:8 dilutions: control \> W-MTA-A \>W-PC\
                                                                                                                                                                                                                                                                                                                                                                                                  White Portland Cement (PC; Votoran)                                                                                                                                               (SET materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 1:6 dilution: MTA-A ≈ control \> PC

  Trypan blue assay                                                                                                                                                                                                                                                                                                                                                                               1:2 dilution: control \> MTA-A \> PC\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                  1:3 dilution: control \> PC \> MTA-A\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                  1:4 and 1:6 dilutions: control \> PC \> MTA-A\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                  1:8 dilution: control \> PC ≈ MTA-A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Cell Differentiation                                                                                                                                                                                                                                                                                                                                                                            ALP activity (at 1, 3 & 7d)                                                                                                                                                       1, 3 and 7 d: MTA-A ≈ PC ≈ control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Rodrigues EM et al. (2017) \[[@B72-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                        MTA-Plus (MTA-P; Prevest Denpro)\                                                                                                                                                 Indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                                 Cell viability                          MTT Assay\                                            1:2 concentration: MTA-P \> MTA-A ≈ control\
                                                                                                                                                                                                                                                                                                                                                                                                  White MTA Angelus (MTA-A; Angelus)                                                                                                                                                (SET materials)(ISO-10993)                                                                                                                                                                                                                                                                                                                                                                                                                                                Flow cytometry--\                                     1:4 and 1:8 concentrations: MTA-P ≈ MTA-A \> control\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Annexin V-PI                                          MTA-A \> live cells than MTA-P ≈ control\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    MTA-A \> necrotic cells than MTA-P \> control

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            ALP activity (at 1, 3 & 7 days)                                                                                                                                                   MTA-A \< control \< MTA-P after 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  ARS (14d)                                                                                                                                                                                                                                                                                                                                                                                       MTA-A \> MTA-P \> control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  qRT-PCR (BMP2, OC, ALP)                                                                                                                                                                                                                                                                                                                                                                         Day 1_BMP2 & OC: MTA-A \> MTA-P \> control; ALP: MTA-A ≈ MTA-P \< control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                  Day 3\_ BMP2: MTA-A \> MTA-P \> control; OC & ALP: MTA-A ≈ MTA-P \< control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Sun Y et al. (2017) \[[@B73-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                               Biodentine (Bd; Septodont)\                                                                                                                                                       Indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                                 Cell proliferation                      CCK-8 assay (1, 3 & 7 days)                           1 d: Bd_0.2 mg/mL ≈ Bd_2 mg/mL ≈ iFS_0.2 mg/mL ≈ iFS_2 mg/mL ≈ control (*p* ≥ 0.05)\
                                                                                                                                                                                                                                                                                                                                                                                                  iRoot FS (iFS; Innovative Bioceramix)                                                                                                                                             (SET materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 3 d: Bd_0.2 mg/mL ≈ Bd_2 mg/mL ≈ iFS_0.2 mg/mL ≈ iFS_2 mg/mL \> control\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    7 d: Bd_0.2 mg/mL ≈ iFS_0.2 mg/mL \> Bd_2 mg/mL ≈ iFS_2 mg/mL \> control

  Cell migration (24 h)                                                                                                                                                                                                                                                                                                                                                                           Wound healing assay\                                                                                                                                                              iFS_0.2 mg/mL \> iFS_2 mg/mL \> control \> Bd_0.2 mg/mL \> Bd_2 mg/mL                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                  Transwell migration assay                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  iFS_0.2 mg/mL \> iFS_2 mg/mL \> control \> Bd_0.2 mg/mL \> Bd_2 mg/mL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            ALP activity (at 7, 14 d)                                                                                                                                                         7 d: iFS_0.2 mg/mL ≈ iFS_2 mg/mL ≈ Bd_0.2 mg/mL \> Bd_2 mg/mL \> control                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  14 d: iFS_0.2 mg/mL \> Bd_0.2 mg/mL \> Bd_2 mg/mL ≈ iFS_2 mg/mL \> control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  ARS (at 21 d)                                                                                                                                                                                                                                                                                                                                                                                   21 d: iFS_0.2 mg/mL \> Bd_0.2 mg/mL ≈ Bd_2 mg/mL ≈ iFS_2 mg/mL ≈ control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  qRT-PCR (Col I and OCN) (at 1, 7 & 14 d)                                                                                                                                                                                                                                                                                                                                                        1 d: Col I control ≥ all materials\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                  OCN iFS_2 mg/mL ≥ iFS_0.2 mg/mL ≈ Bd_0.2 mg/mL ≈ Bd_2 mg/mL ≈ control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                  7 d: Col I control \> iFS_0.2 mg/mL \> Bd_0.2 mg/mL \> Bd_2 mg/mL \> iFS_2 mg/mL\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                  OCN iFS_0.2 mg/mL \> control ≈ iFS_2 mg/mL \> Bd_2 mg/mL ≥ Bd_0.2 mg/mL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  14 d: Col I iFS_0.2 mg/mL \> Bd_0.2 mg/mL ≈ Bd_2 mg/mL ≥ control ≥ iFS_2 mg/mL\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  OCN iFS_0.2 mg/mL ≈ iFS_2 mg/m ≥ control ≥ Bd_0.2 mg/mL ≥ Bd_2 mg/mL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Tomás -Catalá et al. (2017) \[[@B74-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                       MTA-repair HP Angelus (MTA-HP; Angelus)\                                                                                                                                          Indirect and direct contact (SET materials) (ISO 10993-5)                                                                                                                                                                                                                                                                                                                                                                         Cell morphology                         SEM-EDX\                                              Cells attached and merged in all three materials, more cell monolayer structures were evident on the surface of W-MTA.\
                                                                                                                                                                                                                                                                                                                                                                                                  NeoMTA-Plus (N-MTA-P; Avalon Biomed Inc)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   (direct contact, 72 h)                                EDX revealed MTA-HP ≈ N-MTA-P ≈ W-MTA in %weight of Ca, C and O.
                                                                                                                                                                                                                                                                                                                                                                                                  White MTA Angelus (W-MTA; Angelus)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Cell Viability (24, 48 & 72 h)                                                                                                                                                                                                                                                                                                                                                                  MTT assay                                                                                                                                                                         24 h all dilutions: MTA-HP ≈ N-MTA-P ≈ W-MTA ≈ control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    48 h undiluted extract: MTA-HP ≈ W-MTA \> control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    48 h 1:2 dilution: MTA-HP ≈ N-MTA-P ≈ W-MTA ≈ control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    48 h 1:4 dilution: W-MTA \> control ≈ MTA-HP \> N-MTA-P\                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h undiluted extract: W-MTA \> N-MTA-P \> MTA-HP \> control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h 1:2 dilution: MTA-HP ≈ N-MTA-P ≈ W-MTA ≈ control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h 1:4 dilution: MTA-HP \< control ≈ N-MTA-P ≈ W-MTA                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Cell migration (24 & 48 h)                                                                                                                                                                                                                                                                                                                                                                      Wound healing--scratch assay                                                                                                                                                      N-MTA-P \< control for all dilutions and time points\                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    MTA-HP-A \> control at 24 h_1:1/1:2 dilutions but \< control at 48 h\                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    W-MTA-A \> control at 24 h_all dilutions but \< control at 48 h                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Collado-González M et al. (2018) \[[@B75-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                  GI Equia Forte (EF; GC)\                                                                                                                                                          Indirect and direct contact (SET materials)\                                                                                                                                                                                                                                                                                                                                                                                      Cell morphology\                        Confocal microscopy\                                  1:1 extracts EF ≈ control (an organized and stretched stress fiber)\
                                                                                                                                                                                                                                                                                                                                                                                                  GI Ionostar Molar (IoM;Voco)                                                                                                                                                      (ISO 10993-5)                                                                                                                                                                                                                                                                                                                                                                                                                     (indirect contact, 24 h)                (cytoskeletal F-actin)                                1:1 extracts IoM \< control (cell numbers and stretched stress fiber)

  Cell morphology\                                                                                                                                                                                                                                                                                                                                                                                SEM                                                                                                                                                                               EF \> IoM (cell attachment, morphology and growth)                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  (direct contact, 72 h)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Cell Viability (at 24, 48 & 72 h)                                                                                                                                                                                                                                                                                                                                                               MTT assay                                                                                                                                                                         24 h all concentrations: Control \> EF ≈ IoM\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    48 h 1:1 dilution: Control ≈ IoM \> EF;\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    48 h 1:2 dilution: IoM ≈ EF ≈ control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    48 h 1:4 dilution: IoM ≈ EF ≈ control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h 1:1 dilution: EF ≈ control \> IoM\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h 1:2 dilution: control \> IoM ≈ EF\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    72 h 1:4 dilution: control \> EF \> IoM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Cell migration (24 and 48 h)                                                                                                                                                                                                                                                                                                                                                                    Scratch assay                                                                                                                                                                     Control \> EF \> IoM for all concentrations and study periods                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Cell differentiation                                                                                                                                                                                                                                                                                                                                                                            Flow cytometry--\                                                                                                                                                                 IoM and EF ≈ control (the percentage of positive expression of mesenchymal markers)                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                  Annexin V/7-AAD staining                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Pedano MS et al. (2018) \[[@B76-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                           Exp-PPL (PPL)\                                                                                                                                                                    Indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                                 Cell viability (24 h)                   XTT assay                                             10% eluates: Bd \> PPL ≈ Nex-MTA \> ZnO\
                                                                                                                                                                                                                                                                                                                                                                                                  Biodentine (Bd; Septodont)\                                                                                                                                                       (FRESH materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               25% eluates: PPL \> Nex-MTA \> Bd \> ZnO\
                                                                                                                                                                                                                                                                                                                                                                                                  Nex-Cem MTA (Nex-MTA; GC)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        50% eluates: PPL ≈ Nex-MTA \> Bd \> ZnO\
                                                                                                                                                                                                                                                                                                                                                                                                  Zinc-oxide eugenol Alganol (ZnO; Kemdent)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         100% eluates: Nex-MTA \> PPL \> Bd \> ZnO

  Cell proliferation (1, 4 & 7 d)                                                                                                                                                                                                                                                                                                                                                                 XTT assay                                                                                                                                                                         10% eluates 7d: PPL ≈ Bd ≈ control \> Nex-MTA \> ZnO\                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    25% eluates 7d: control \> Bd \> PPL \> Nex-MTA \> ZnO\                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    50% eluates 7d: control \> Bd \> PPL \> Nex-MTA \> ZnO\                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    100% eluates 7d: control \> PPL ≈ Bd ≈ Nex-MTA \> ZnO                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Cell migration (24 h)                                                                                                                                                                                                                                                                                                                                                                           Scratch-wound healing assay                                                                                                                                                       10% and 25% eluates: control ≈ PPL ≈ Nex-MTA \> Bd\                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    50% eluates: control ≈Nex-MTA ≈ PPL \> Bd\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    100% eluates: control \> PPL \> Nex-MTA \> Bd                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Cell differentiation (4, 10 & 14 d)                                                                                                                                                                                                                                                                                                                                                             RT-PCR (ALP, OCN, DSPP)                                                                                                                                                           ALP 4 d: differentiation medium \> PPL ≈ Bd ≈ Nex-MTA\                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    10 d: differentiation medium ≈ PPL ≈ Bd ≈ Nex-MTA\                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    14 d: differentiation medium \> PPL \> Bd ≈ Nex-MTA\                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    OCN 14d: PPL ≈ Bd \> Nex-MTA ≈ differentiation medium\                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    DSPP 10 d: PPL ≈ Bd ≈ Nex-MTA ≈ differentiation medium\                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    14 d: Bd \> PPL \> differentiation medium \> Nex-MTA                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Tomás-Catalá CJ\                                                                                                                                                                                                                                                                                                                                                                                Biodentine (Bd; Septodont)MTA Repair HP Angelus\                                                                                                                                  Indirect and direct contact (SET materials) (ISO 10993-5)                                                                                                                                                                                                                                                                                                                                                                         Cell attachment                         SEM-EDX (direct contact, 72 h)                        SEM showed Bd revealed more cells and with better morphology than MTA-HP-A and N-MTA-P. The EDX revealed that Bd, MTA-HP-A and N-MTA-P had similar percentages of Ca, C and O.
  et al. (2018) \[[@B77-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                                     (MTA-HP-A; Angelus)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                  NeoMTA Plus (N-MTA-P; Avalon Biomed Inc)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Cell viability                                                                                                                                                                                                                                                                                                                                                                                  MTT assay (24, 48 & 72 h)                                                                                                                                                         Undiluted extract: Bd \> MTA-HP-A \> N-MTA-P \> control at 48 h and 72 h\                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1:2 dilution: Bd \> MTA-HP-A ≈ N-MTA-P ≈ control (*p* \< 0.01) at 48 h and 72 h\                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1:4 dilution: Bd \> N-MTA-P ≈ control \> MTA-HP-A at 72 h                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Cell migration                                                                                                                                                                                                                                                                                                                                                                                  Scratch assay (at 24 & 48 h)                                                                                                                                                      24 h: Bd \> MTA-HP-A ≈ N-MTA-P ≈ control (*p* \< 0.01)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    48 h: Bd \> control for all dilutions; control \> N-MTA-P \> MTA-HP-A                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Lee S-M et al. (2019) \[[@B78-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                             Smart Dentin Replacement (SDR; Dentsply-Sirona)\                                                                                                                                  Indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                                 Cell viability                          WST assay (24 h)\                                     2-mm-cured composite: ≈ 100% cell-viability except for BFF (49%)\
                                                                                                                                                                                                                                                                                                                                                                                                  Venus Bulk-fill (VBF; Hereaus Kulzer)\                                                                                                                                            (Set materials)\                                                                                                                                                                                                                                                                                                                                                                                                                                                          Live/dead Assay\                                      4-mm-cured composite: SDR not cytotoxic at all dilutions.\
                                                                                                                                                                                                                                                                                                                                                                                                  Beautifil Bulk flowable (BBF; Shofu)\                                                                                                                                             (ISO 10993-5)                                                                                                                                                                                                                                                                                                                                                                                                                                                             (direct visualization with confocal microscopy)       VBF & BBF statistically different values (71.05% and 64.43%, respectively) of cell viability at 100% concentration compared to control (*p* \< 0.05) but no statistically different cell viability compared to control at 25% and 12.5% concentrations, respectively (\~100%, *p* \> 0.05)\
                                                                                                                                                                                                                                                                                                                                                                                                  Filtek Z350 XT Flowable (ZFF; 3M)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 6-mm-cured composite: SDR and BBF were \~69% and \~6% at 100% concentration (*p* \< 0.05), and these resins did not show statistically different cell viability compared to control at 25% and 12.5% (\~100%, *p* \> 0.05), respectively. In contrast, VBF and ZFF did not reach non-cytotoxic levels (\~100%) even at 12.5% dilution.

  At 100% concentrations of SDR, VBF, and ZFF, 6-mm cured composite showed 5\~60% live cell numbers compared to the 2-mm cured group. Another bulk-fill resin, BBF, had 5\~35% live cells with some dead cells in all groups. At 12.5%, there were full of live cells at all groups while the 4-mm cured ZFF and the 6-mm cured VBF and ZFF revealed fewer live cells (\~75%) than the control.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Cell differentiation\                                                                                                                                                                                                                                                                                                                                                                           ALP staining                                                                                                                                                                      6-mm-cured bulk-fill resins showed significantly lower ALP staining than the differentiation media control (*p* \< 0.05), while all 2-mm and 4-mm cured bulk-fill resins showed similar ALP staining, except for 4-mm-cured BBF. ALP staining from the bulk-fill resins was ranked as follows: 2-mm \> 4-mm \> 6-mm cured. The flowable resin, ZFF, exhibited the least amount of ALP staining between the experimental groups.                                                                                                 
  (7 days)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  López-García et al. (2019) \[[@B79-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                        Activa *Kids* (Activa; Pulpdent)\                                                                                                                                                 Indirect and direct contact\                                                                                                                                                                                                                                                                                                                                                                                                      Cell morphology (indirect contact)      Immunofluorescence                                    Activa \> cell density and spreading than Riva \> Inolux
                                                                                                                                                                                                                                                                                                                                                                                                  GI Ionolux (Voco)\                                                                                                                                                                (Set materials)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                  Riva Light Cure (Riva; SDI)                                                                                                                                                       (ISO 10993-5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Cell attachment/adhesion (direct contact)                                                                                                                                                                                                                                                                                                                                                       SEM                                                                                                                                                                               Activa showed well-adhered fibroblastic cells with multiple cytoplasmic extensions.\                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Riva showed less density and fewer cells than Activa.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Ionolux induced drastic reduction in cell density and attachement.                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Cell viability                                                                                                                                                                                                                                                                                                                                                                                  MTT assay (1, 2 & 4 days)                                                                                                                                                         24 h - Undiluted extracts: Activa ≈ control \> Riva \> Ionolux (*p* \< 0.01)\                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    24 h--1:2 dilution: Activa ≈ control ≈ Riva \> Ionolux\                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    24 h--1:4 dilution: Activa ≈ control \> Riva \> Ionolux\                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    48 h-Undiluted extracts: Ionolux \< Activa & Riva (*p* \< 0.01) \< control (*p* \< 0.01)\                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    48 h--1:2 dilution: Activa & Riva & Ionolux ≈ control\                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    48 h--1:4 dilution: Activa & Riva & Ionolux ≈ control                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  72 h-Undiluted extracts: Control \> Activa \> Riva \> Ionolux\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  72 h--1:2 dilution: Control \> Activa \> Riva \> Ionolux\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  72 h--1:4 dilution: Activa ≈ control; Riva & Ionolux \< control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Cell migration                                                                                                                                                                                                                                                                                                                                                                                  Wound healing assay                                                                                                                                                               Activa ≈ control at all dilutions except 1:2 at 72 h\                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Riva \< migration than control except 1:4 dilution\                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Ionolux \< migration than control except 1:4 dilution at 24 h and 48 h\                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Dou L et al. (2020) \[[@B80-materials-13-02670]\]                                                                                                                                                                                                                                                                                                                                               Dycal (Dentsply-Sirona)\                                                                                                                                                          Indirect contact\                                                                                                                                                                                                                                                                                                                                                                                                                 Cell viability                          Trypan Blue Staining\                                 Dycal \< cell viability than MTA ≈ iRoot ≈ PRF ≈ CGF ≈ control at 1, 3 & 7 days
                                                                                                                                                                                                                                                                                                                                                                                                  Pro-Root MTA (MTA; Dentsply-Sirona)\                                                                                                                                              (Set materials)                                                                                                                                                                                                                                                                                                                                                                                                                                                           (1, 3 & 7 days)\                                      
                                                                                                                                                                                                                                                                                                                                                                                                  iRoot BP (iRoot; Innovative Bioceramix)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Flow cytometry--\                                     
                                                                                                                                                                                                                                                                                                                                                                                                  Platelet-rich Fibrin (PRF)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Annexin V-PI\                                         
                                                                                                                                                                                                                                                                                                                                                                                                  Concentrated Growth Factors (CGF)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           (1, 3 & 7 days)\                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Cell Cycle(1, 3 & 7 days)                             

  Dycal \> apoptotic cells than MTA ≈ iRoot ≈ CGF ≈ control at 1, 3 & 7 days\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Days 1 & 3: no significant differences among the groups\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  Day 7: CGF showed less cells in G~0~/G~1~-phase compared to MTA & Dycal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Cell proliferation                                                                                                                                                                                                                                                                                                                                                                              CCK-8                                                                                                                                                                             Day 1: Dycal \< cell proliferation than all groups; MTA ≈ iRoot ≈ PRF ≈ CGF ≈ control.\                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Day 3: PRF & CGF \> cell proliferation than control & MTA, but ≈ iRoot; Dycal \< all groups\                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Day 7: CGF \> cell proliferation than iRoot & MTA, but ≈ control &PRF; Dycal \< all groups                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Cell differentiation\                                                                                                                                                                                                                                                                                                                                                                           ALP staining                                                                                                                                                                      Days 1 & 3: MTA \> ALP-activity than control; Control ≈ iRoot ≈ PRF ≈ CGF ≈ Dycal\                                                                                                                                                                                                                                                                                                                                                                                                                                              
  (1,3 & 7 days)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Day 7: Dycal \< ALP-activity than CGF; CGF ≈ control ≈ MTA ≈ iRoot ≈ PRF                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------- ----------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* Direct contact was considered when the cells were seeded on top of the materials. When the material was placed on a transwell insert or materials' eluates were used, it was considered INDIRECT contact.

materials-13-02670-t003_Table 3

###### 

Included in vivo studies (immature permanent teeth).

  -------------------------------------------------------------- ---------------- ------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------- -------------------------- --------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------
  **Authors**                                                    **Study Type**   **Hemostasia**                              **Materials Used**                                                                                                                                                                 **Etched Pulp?**             **Evaluation Period(s)**   **Bridge Formation**                                                                                                              **Inflammation**                                                                                                                                                                                                            **Sample**

  Hebling J et al. (1999) \[[@B81-materials-13-02670]\]          CCT              Sterile cotton pellets + sterile saline     Calcium-hydroxide saline paste (CH) + calcium-hydroxide cement (Dycal; Dentsply-Sirona)\                                                                                           No (CH), Yes (AB2)           7 days\                    CH: 3/4 teeth showed complete bridge formation at 30 days. 4/4 teeth showed complete bridge below exposed area at 60 days.\       CH: 1/4 teeth showed moderate and 3/4 slight inflammation at day 7.\                                                                                                                                                        32 premolars (12--15 years old patients)
                                                                                                                              All Bond 2 (AB2; Bisco)                                                                                                                                                                                         30 days\                   AB2: 0/6 teeth showed completed bridge at 30 or 60 days (0/12 in total). All of them showed modest bridge formation at 60 days.   At day 30, 4/4 teeth showed slight inflammatory reaction. No tooth showed severe inflammation\                                                                                                                              
                                                                                                                                                                                                                                                                                                                                              60 days                                                                                                                                                      AB2: 1/6 teeth showed severe inflammatory reaction, 3/6 moderate and 2/6 slight inflammation at day 7. At day 30, 3/6 showed moderate and 3/6 slight inflammatory reaction.                                                 

  Do Nascimento AB et al. (2000) \[[@B82-materials-13-02670]\]   CCT              Sterile paper cones + sterile saline        Calcium-hydroxide saline paste (CH; Pathfinder associates) + calcium hydroxide cement (Dycal; Dentsply-Sirona)Resin-modified glass-ionomer cement (Vit; Vitrebond; 3M Oral Care)   No                           5 days\                    CH: 1/4 teeth showed complete bridge at 30 days. 5/5 teeth showed complete bridge at 120+ days.\                                  CH: at day 5, 0/6 teeth showed no inflammation, 4/6 teeth showed slight, 2/6 moderate and 0/6 severe inflammation. At day 30, 3/4 showed slight and 1/4 moderate inflammation.\                                             34 premolars (11--17 years old patients)
                                                                                                                                                                                                                                                                                                                                              30 days\                   Vit: 0/6 teeth showed complete bridge at 30 days. 0/5 teeth showed complete bridge at 120+ days.                                  Vit: 0/5 teeth showed none inflammatory reaction, 1/5 teeth showed slight and 4/5 moderate inflammation at day 5. At day 30, 2/6 showed slight and 4/6 moderate inflammatory reaction.                                      
                                                                                                                                                                                                                                                                                                                                              120+ days                                                                                                                                                                                                                                                                                                                                                                                

  Costa CAS et al. (2001) \[[@B83-materials-13-02670]\]          CCT              Sterile paper cones + sterile saline        Calcium-hydroxide saline paste (CH; Pathfinder associates) + calcium hydroxide cement (Dycal; Dentsply-Sirona)\                                                                    No                           5 days\                    CH: 1/4 teeth showed complete bridge at 30 days. 5/5 teeth showed complete bridge at 120+ days.\                                  CH: at day 5, 1/6 teeth showed none inflammatory reaction, 3/6 teeth showed slight, 2/6 moderate and 0/6 severe inflammation. At day 30, 3/4 showed slight and 1/4 moderate inflammation.\                                  36 premolars (11--17 years old patients)
                                                                                                                              Clearfil Liner Bond 2 (CLB2; Kuraray Noritake)                                                                                                                                                                  30 days\                   CLB2: 0/5 teeth showed complete bridge at 30 days. 0/6 teeth showed complete bridge at 120+ days.                                 CLB2: 4/6 teeth showed slight and 2/6 moderate inflammation at day 5. At day 30, 2/5 showed slight and 3/5 moderate inflammatory reaction.                                                                                  
                                                                                                                                                                                                                                                                                                                                              120+ days                                                                                                                                                                                                                                                                                                                                                                                

  Ersin EK et al. (2005) \[[@B84-materials-13-02670]\]           CCT              3% H~2~O~2~                                 Calcium-hydroxide saline paste (CH) + calcium hydroxide cement (Dycal; Dentsply-Sirona)\                                                                                           No                           7 days\                    CH: 5/5 teeth showed complete bridge after 90 days.\                                                                              CH: 5/5 teeth showed slight inflammatory reaction at day 7.\                                                                                                                                                                20 premolars (mean age 12.6 years) Age range not available
                                                                                                                              Prime&Bond 2.1 (P&B2.1; Dentsply-Sirona)                                                                                                                                                                        90 days                    P&B2.1: 0/5 teeth showed complete bridge after 90 days.                                                                           P&B2.1: at 7 days, 5/5 teeth showed moderate acute inflammatory reaction. 0/5 teeth showed severe inflammation or necrotic tissue.                                                                                          

  Olsson H et al. (2005) \[[@B85-materials-13-02670]\]           RCT              Continuous irrigation with sterile saline   Calcium-hydroxide saline paste (CH)\                                                                                                                                               No                           12 weeks                   CH: 9/9 teeth showed complete bridge at 12 weeks.\                                                                                12 weeks                                                                                                                                                                                                                    18 premolars (12--16 years old patients)
                                                                                                                              Enamel matrix derivative (EMD; Emdogain, BIORA)                                                                                                                                                                                            EMD: 0/9 teeth showed complete bridge at 12 weeks.                                                                                                                                                                                                                                                                                                            

  Silva GAB et al. (2006) \[[@B86-materials-13-02670]\]          RCT              Sterile cotton pellets + sterile saline     Calcium-hydroxide powder (CH; PA Biodinamica) + calcium hydroxide cement (Dycal; Dentsply-Sirona)\                                                                                 No (CH), Yes (10%-37%; SB)   1 day\                     CH: 5/5 teeth showed complete bridge at day 30.\                                                                                  CH: 0/20 showed severe inflammatory reaction at days 1-3-7 or 30 (5/time period). 10/20 teeth showed slight and 10/20 teeth showed moderate inflammation at 1-3-7 or 30 days.\                                              81 premolars (12--17 years old patients)
                                                                                                                              Single Bond (SB; 3M Oral Care)                                                                                                                                                                                  3 days\                    SB-10% Etch: 0/5 teeth showed complete bridge at day 30.\                                                                         SB-10% Etch: 0/20 showed severe inflammatory reaction at days 1-3-7 or 30 (5/time period). 1/20 teeth showed none/few inflammatory cells at d1. 5/20 teeth showed slight and 14/20 moderate inflammatory reaction.\         
                                                                                                                                                                                                                                                                                                                                              7 days\                    SB-37% Etch: 0/5 teeth showed complete bridge at day 30.                                                                          SB-37% Etch: 0/20 showed severe inflammatory reaction at days 1-3-7 or 30 (5/time period). 1/20 teeth showed none/few inflammatory cells at d1. 10/20 teeth showed slight and 9/20 moderate inflammation at 1-3-7 or 30d.   
                                                                                                                                                                                                                                                                                                                                              30 days                                                                                                                                                                                                                                                                                                                                                                                  

  Sawicki L et al. (2008) \[[@B87-materials-13-02670]\]          RCT              Sterile cotton pellets + sterile saline     Calcium-hydroxide cement (Life; Kerr)\                                                                                                                                             No                           47+ days                   Life: 11/14 teeth showed complete bridge after 47+ days.\                                                                         47+ days!                                                                                                                                                                                                                   48 premolars (10--18 years old patients)
                                                                                                                              White Pro-Root MTA (W-MTA; Dentsply-Sirona)                                                                                                                                                                                                WMTA: 28/30 teeth complete bridge.\                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                         4 teeth lost (not reported)                                                                                                                                                                                                                                                                                                                                   

  Azimi S et al. (2014) \[[@B88-materials-13-02670]\]            RCT              Sterile cotton pellets + sterile saline     White Pro-Root MTA (W-MTA; Dentsply-Sirona)\                                                                                                                                       No                           6 weeks                    WMTA: 8/12 teeth showed complete bridge formation at 6 weeks.\                                                                    6 weeks!!                                                                                                                                                                                                                   24 premolars (12--16 years old)
                                                                                                                              iRoot BP (iRoot; Innovative Bioceramix)                                                                                                                                                                                                    iRoot: 7/12 teeth showed complete bridge at 6 weeks.                                                                                                                                                                                                                                                                                                          

  Swarup SJ et al. (2014) \[[@B89-materials-13-02670]\]          RCT              Sterile cotton pellets + sterile saline     Calcium-hydroxide cement (Dycal; Dentsply)\                                                                                                                                        No                           15 days\                   Dycal: 2/5 had a complete bridge at 30d.\                                                                                         Dycal: 4/5 showed moderate and 1/5 severe inflammatory reaction day 15. 1/5 teeth showed moderate and 4/5 slight inflammation at day 30.\                                                                                   30 premolars (11--15 years old)
                                                                                                                              MTA Angelus (MTA-A; Angelus)\                                                                                                                                                                                   30 days                    MTA-A: 4/5 had complete bridge 30d.\                                                                                              MTA-A: 3/5 teeth showed none and 2/5 teeth showed slight inflammatory reaction at day 15. At day 30, 4/5 teeth showed none or few inflammations and 1/5 showed slight inflammatory reaction.\                               
                                                                                                                              Nanohydroxyapatite (Hap; Orthogran)                                                                                                                                                                                                        Hap: 4/5 teeth had complete bridge.                                                                                               Hap: 3/5 showed moderate inflammatory reaction and 2/5 severe inflammation (day 15). 3/5 showed no inflammation and 2/5 slight inflammatory reaction at day 30.                                                             

  Banava S et al. (2015) \[[@B90-materials-13-02670]\]           RCT              Sterile cotton pellets + sterile saline     Calcium-hydroxide cement (Dycal; Dentsply-Sirona)\                                                                                                                                 No                           6 weeks                    Dycal: 7/8 teeth showed bridge at 6w.\                                                                                            6 weeks!!                                                                                                                                                                                                                   32 premolars (13--20 years old)
                                                                                                                              White-MTA (WMTA; Dentsply-Sirona)Pulpdent Multi-Cal Liner (PML; Pulpdent)                                                                                                                                                                  WMTA: 12/16 teeth sowed bridge formation at 6w.\                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                         PML: 2/8 teeth showed bridge formation at 6w.                                                                                                                                                                                                                                                                                                                 
  -------------------------------------------------------------- ---------------- ------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------- -------------------------- --------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------

materials-13-02670-t004_Table 4

###### 

Included in vivo studies (mature permanent teeth).

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                                                          Study Type   Hemostasia                                                                                   Materials Used                                                                                                    Etched Pulp?                   Evaluation Period(s)   Bridge Formation                                                                                                                                                                                        Inflammation                                                                                                                                                                           Sample
  ---------------------------------------------------------------- ------------ -------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------- ------------------------------ ---------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------
  Demarco FF et al. (2001) \[[@B91-materials-13-02670]\]           RCT          Sterile cotton pellets + sterile saline                                                      Calcium-hydroxide powder (CH; Labrynth Produtos) + calcium-hydroxide cement Hydro C (Dentsply-Sirona)\            Yes (SBMP), No (CH and CLB2)   30 days\               CH: 2/2 complete bridges formed at 30 and 2/2 at 90 days\                                                                                                                                               CH: 0/2 teeth showed severe inflammation or necrosis at 30 days.\                                                                                                                      20 molars\
                                                                                                                                                                             Scotchbond Multipurpose (SBMP; 3M)\                                                                                                              90 days                SBMP: 0/4 teeth with bridges formed at 30 and 0/4 at 90 days.\                                                                                                                                          SBMP: 1/4 teeth showed severe inflammation or necrosis at 30 days.\                                                                                                                    (20--27 years old patients)
                                                                                                                                                                             Clearfil Liner Bond 2 (CLB2; Kuraray Noritake)                                                                                                                          CLB2: 1/4 teeth showed bridge at 30 days. 2/4 teeth showed bridge formation at 90 days.                                                                                                                 CLB2: 0/4 teeth showed severe inflammation or necrosis at 30 days.                                                                                                                     

  Accorinte MLR et al. (2005) \[[@B92-materials-13-02670]\]        RCT          Sterile cotton pellets + sterile saline                                                      Calcium-hydroxide powder (CH; Labrynth Produtos) + calcium-hydroxide cement (Dycal; Dentsply-Sirona)\             Yes (SBMP), No (CH)            60 days                CH: 100% (5/5) of the teeth showed brige formation at day 60.\                                                                                                                                          60 days                                                                                                                                                                                25 premolars (15--25 years old patients)
                                                                                                                                                                             Scotchbond Multipurpose (SBMP; 3M Oral Care)                                                                                                                            SBMP: 0% (0/5) of the teeth showed bridge formation                                                                                                                                                                                                                                                                                                                                            

  Accorinte MLR et al. (2006) \[[@B93-materials-13-02670]\]        RCT          Sterile cotton pellets + sterile saline                                                      Calcium-hydroxide powder (CH; Labrynth Produtos) + calcium-hydroxide cement (Dycal; Dentsply-Sirona)\             Yes (SBMP), No (CH)            30 days\               CH: 100% (5/5) of the teeth showed brige formation at 30 and 60 days.\                                                                                                                                  CH: no to mild inflammatory reaction all teeth (5/5) at 30 days.\                                                                                                                      40 premolars (15--25 years old patients)
                                                                                                                                                                             Scotch Bond Multipurpose (SBMP; 3M Oral Care)                                                                                                    60 days                SBMP: 0% (0/5) of the teeth showed bridge formation at 30 or 60 days.                                                                                                                                   SBMP: 2/5 teeth (40%) showed pulp necrosis at day 30.                                                                                                                                  

  Iwamoto CE et al. (2006) \[[@B94-materials-13-02670]\]           RCT          Sterile cotton pellets + sterile saline                                                      Calcium-hydroxide cement (Dycal; Dentsply-Sirona)\                                                                No                             112+ days              Dycal: 18/23 teeth developed bridge formation at 110+ days.\                                                                                                                                            112+ days                                                                                                                                                                              48 molars\
                                                                                                                                                                             White Pro-Root MTA (W-MTA; Dentsply-Sirona)                                                                                                                             W-MTA: 20/22 teeth developed bridge formation.                                                                                                                                                                                                                                                                                                                                                 (18--60 years old patients)

  Accorinte MLR et al. (2007) \[[@B95-materials-13-02670]\]        CCT          Sterile cotton pellets + sterile saline; sterile cotton pellets + 2.5% sodium hypochlorite   Calcium-hydroxide cement (Life; Kerr)                                                                             No                             30 days\               Life: 2/10 teeth (20%) showed bridge formation at 30 days. At day 60, 6/10 teeth showed complete bridge formation. At day 60, only 1/10 teeth showed absent bridge.                                     Life: At day 30, 8/10 teeth showed no inflammation and 1/10 showed mild inflammatory reaction. Only 1/10 teeth showed severe inflammation.                                             40 premolars (15--30 years old patients)
                                                                                                                                                                                                                                                                                                                              60 days                                                                                                                                                                                                                                                                                                                                                                                                               

  Elias RV et al. (2007) \[[@B96-materials-13-02670]\]             RCT          Sterile cotton pellets + 2.5% sodium hypochlorite                                            Calcium-hydroxide powder (CH; Labrynth Produtos) + calcium-hydroxide cement Hydro C (Dentsply-Sirona)\            No                             30 day\                CH: 5/5 complete bridge after 30 days and 5/5 at 90 days.\                                                                                                                                              CH: 5/5 teeth showed none or slight inflammation after 30 days for all specimens.\                                                                                                     26 molars (average 25 years)\
                                                                                                                                                                             Clearfil SE Bond (CSE; Kuraray Noritake)                                                                                                         90 days                CSE: 1/8 specimens showed dentin deposition at the interface (complete bridge) at 90 days. 0/8 teeth showed complete bridge at 30 days. 3/8 specimens showed no dentin deposition at all.               CSE: 4/8 specimens showed no inflammation; 3/8 specimens slight inflamm; 1/8 severe inflammation at 30 days.                                                                           Age range not provided

  Accorinte MLR et al.\                                            CCT          Sterile cotton pellets + sterile saline                                                      Calcium-hydroxide cement (Life; Kerr)\                                                                            No                             30 days\               Life: 2/10 teeth showed complete bridge at 30 days and 6/10 complete bridge after 60 days\                                                                                                              Life: all teeth showed absent (8/10) or mild (2/10) inflammatory reaction at 30 days. 1/10 teeth showed slight and 1/10 moderate inflammatory reaction.\                               40 premolars (15--30 years old patients)
  (2008) \[[@B53-materials-13-02670]\]                                                                                                                                       Pro-Root MTA (MTA; Dentsply-Sirona)                                                                                                              60 days                MTA: 3/10 teeth showed complete bridge at 30 days and 5/10 teeth complete bridge after 60 days                                                                                                          No teeth showed necrosis or abscess formation at 30 days.MTA: all teeth showed absent (9/10) or mild (1/10) inflammatory reaction at 30 days.\                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             No teeth showed necrosis or abscess formation at 30 days.                                                                                                                              

  Accorinte MLR et al. (2008) \[[@B52-materials-13-02670]\]        CCT          Sterile cotton pellets + sterile saline                                                      Calcium-hydroxide powder (CH) + calcium-hydroxide cement (Life; Kerr)\                                            No                             30 days\               CH: 6/10 teeth showed complete bridge at 30 days and 8/10 teeth showed complete bridge after 60 days\                                                                                                   CH: 8/10 teeth showed absent or slight inflammatory reaction at 30 days.\                                                                                                              40 premolars (15--30 years old patients)
                                                                                                                                                                             MTA Angelus (MTA-A; Angelus)                                                                                                                     60 days                MTA-A: 4/10 teeth showed complete bridge at 30 days and 7/10 complete bridge after 60 days                                                                                                              No teeth showed necrosis or abscess formation at 30 days.\                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             MTA-A: 8/10 teeth showed absent or slight inflammatory reaction at 30 days. 1/10 teeth showed severe inflammation (abscess formation) at 30 days.                                      

  Accorinte MLR et al. (2008) \[[@B97-materials-13-02670]\]        CCT          Sterile cotton pellets + sterile saline                                                      Calcium-hydroxide cement (Dycal; Dentsply-Sirona)\                                                                No                             30 days\               Dycal: 8/9 teeth with complete bridge formed at day 90. No CH treated teeth extracted at 30 days.\                                                                                                      Dycal: no teeth were extracted at 30 days for CH group.\                                                                                                                               34 premolars (15--30 years old patients)
                                                                                                                                                                             Clearfil Liner Bond 2V (C2V; Kuraray Noritake)\                                                                                                  90 days                C2V: 1/4 teeth complete bridge at 30 days. 1/6 teeth with complete bridge at day 90 and 2/6 with absence or discrete bridge\                                                                            C2V: All teeth had slight (2/6) or moderate (3/6) inflammation after 30 days including 1/6 teeth with abscess.\                                                                        
                                                                                                                                                                             Clearfil SE Bond (CSE; Kuraray Noritake)                                                                                                                                CSE: 0/5 teeth complete bridge at 30 days. 1/6 teeth with complete bridge at day 90 and 4/6 with absence or discrete bridge                                                                             CSE: All teeth had slight (3/6) or moderate (2/6) inflammation after 30 days including 1/6 teeth with abscess.                                                                         

  Lu Y et al. (2008) \[[@B98-materials-13-02670]\]                 RCT          Sterile cotton pellets + 2% chlorhexidine + sterile saline                                   Calcium-hydroxide cement (Dycal; Dentsply-Sirona)\                                                                No                             7 days\                Dycal: 1/6 teeth complete bridge at day 30. 5/7 teeth complete bridge deposits after 90 days.\                                                                                                          Dycal: 2/7 teeth showed slight, 4/7 moderate and 1/7 teeth showed severe inflammatory reaction at day 7. At day 30, 5/6 teeth showed slight and 1/6 moderate inflammatory reaction.\   45 molars\
                                                                                                                                                                             Clearfil SE Bond (CSE; Kuraray Noritake)                                                                                                         30 days\               CSE: 0/7 teeth complete bridge after 30 and 0/7 at 90 days.                                                                                                                                             CSE: 6/7 teeth showed slight and 1/7 moderate inflammatory reaction at both 7 and 30 days.                                                                                             (20--25 years old patients)
                                                                                                                                                                                                                                                                                                                              90 days                                                                                                                                                                                                                                                                                                                                                                                                               

  Min K-S et al. (2008) \[[@B99-materials-13-02670]\]              RCT          Sterile cotton pellets + sterile saline                                                      Calcium-hydroxide cement (Dycal; Dentsply-Sirona)\                                                                No                             2 months               Dycal: 6/10 teeth complete bridge. 4/10 total absence of bridge.\                                                                                                                                       2 months!!                                                                                                                                                                             20 molars\
                                                                                                                                                                             Pro-Root MTA (MTA; Dentsply-Sirona)                                                                                                                                     MTA: 100% complete bridge formation.\                                                                                                                                                                                                                                                                                                                                                          (2--50 years old patients)
                                                                                                                                                                                                                                                                                                                                                     Bridges were significantly thicker with MTA                                                                                                                                                                                                                                                                                                                                                    

  Nair PNR et al. (2008) \[[@B100-materials-13-02670]\]            RCT          1% sodium hypochlorite + sterile saline + paper points                                       Calcium-hydroxide cement (Dycal; Dentsply-Sirona)\                                                                No                             7 days\                Dycal: 1/5 teeth complete bridge and 3/5 partial bridge at day 30.\                                                                                                                                     Dycal: at day 7, 2/4 teeth showed inflammatory reaction, 1 of them with severe inflammation.\                                                                                          33 molars\
                                                                                                                                                                             Pro-Root MTA (MTA; Dentsply-Sirona)                                                                                                              30 days\               At day 90, 2/4 teeth partial bridge and 0/4 complete bridge at 90 days. Thick bridges with tunnel defects.\                                                                                             At day 30, 1/5 teeth showed severe inflammatory reaction.\                                                                                                                             (18--30 years old patients)
                                                                                                                                                                                                                                                                                                                              90 days                MTA: 3/6 teeth with complete bridge formation at day 30. 4/5 teeth complete bridge formation at day 90.\                                                                                                MTA: 5/6 teeth showed absence of inflammatory reaction and 1/6 showed slight inflammation at day 7.\                                                                                   
                                                                                                                                                                                                                                                                                                                                                     MTA showed thicker and less variable bridges than Dycal.                                                                                                                                                At day 30, 6/6 samples showed no inflammatory reaction.                                                                                                                                

  Accorinte MLR et al.\                                            RCT          Sterile cotton pellets + sterile saline                                                      Pro-Root MTA (MTA; Dentsply-Sirona)\                                                                              No                             30 days\               MTA: 5/8 teeth had complete bridge at day 30.\                                                                                                                                                          MTA: 2/8 teeth showed no inflammation and 6/8 slight inflammatory reaction at day 30.\                                                                                                 35 premolars (25--42 years old patients)
  (2009) \[[@B101-materials-13-02670]\]                                                                                                                                      MTA Angelus (MTA-A; Angelus)                                                                                                                     60 days                5/9 teeth showed complete bridge at day 60.MTA-A: 5/8 teeth had complete bridge at day 30.\                                                                                                             MTA-A: 3/8 teeth showed no inflammation at day 30. 4/8 showed mild inflammatory reaction and 1 tooth showed abscess at day 30.                                                         
                                                                                                                                                                                                                                                                                                                                                     6/10 teeth showed complete bridge at day 60.                                                                                                                                                                                                                                                                                                                                                   

  Kiatwateeratana T et al. (2009) \[[@B102-materials-13-02670]\]   RCT          Moistened sterile cotton pellets                                                             Calcium-hydroxide powder (CH)\                                                                                    No                             6 months               CH: 10/13 teeth showed complete bridge formation\                                                                                                                                                       6 months!                                                                                                                                                                              26 premolars (13--22 years old)
                                                                                                                                                                             Enamel matrix derivative (EMD; Emdogain, BIORA)                                                                                                                         EMD: no tooth showed bridge formation                                                                                                                                                                                                                                                                                                                                                          

  Parolia A et al. (2010) \[[@B103-materials-13-02670]\]           CCT          Moistened sterile cotton pellets                                                             Calcium-hydroxide cement (Dycal; Dentsply-Sirona)\                                                                No                             15 days\               Dycal: 5/6 teeth showed bridge formation at 45 days.\                                                                                                                                                   Dycal: 6/6 teeth showed none or mild inflammation at day 15.\                                                                                                                          36 premolars (15--25 years old)
                                                                                                                                                                             Pro-Root MTA (MTA; Dentsply-Sirona)Propolis powder (Propolis; Ecuadorian Rainforest LLC) mixed with 70% ethanol                                  45 days                MTA: 6/6 teeth showed bridge formation at day 45.\                                                                                                                                                      MTA: all teeth (6/6) showed none or mild inflammation at day 15.\                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                     Propolis: 6/6 teeth showed bridge formation at 45 days.                                                                                                                                                 Propolis: 6/6 teeth showed none or mild inflammation at day 15.                                                                                                                        

  Nowicka A et al. (2013) \[[@B104-materials-13-02670]\]           CCT          Sterile cotton pellets + sterile saline                                                      White Pro-Root MTA (W-MTA; Dentsply-Sirona)\                                                                      No                             6 weeks                W-MTA: 7/11 teeth had complete bridge. All teeth formed bridges.\                                                                                                                                       6 weeks!                                                                                                                                                                               28 molars (19--28 years old patients)
                                                                                                                                                                             Biodentine (Biodentine; Septodont)                                                                                                                                      Biodentine: 6/11 teeth had complete bridge. All teeth formed bridges.                                                                                                                                                                                                                                                                                                                          

  Nowicka A et al. (2016) \[[@B105-materials-13-02670]\]           RCT          Sterile cotton pellets + sterile saline                                                      Calcium hydroxide paste (Calcipast; Cerkamed) + Calcium hydroxide cement (Life, Kerr)\                            No                             6 weeks                Calcipast: all teeth showed bridge formation with 5/11 teeth showing complete bridge at 6 wk SBU: none of the teeth showed complete bridge formation. 7/11 teeth showed no bridge formation at 6 wks.   6 weeks!                                                                                                                                                                               28 molars\
                                                                                                                                                                             Single Bond Universal (SBU; 3M Oral Care)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              (19--28 years old patients)

  Bakhtiar H et al. (2017) \[[@B106-materials-13-02670]\]          RCT          Sterile cotton pellets                                                                       Theracal LC (Theracal; Bisco)\                                                                                    No                             8 weeks                Theracal: 2/9 teeth showed no bridge formation at 8 wks. 1/9 teeth showed complete bridge at 8 wks.\                                                                                                    8 weeks!                                                                                                                                                                               27 molars\
                                                                                                                                                                             Biodentine (Biodentine; Septodont)\                                                                                                                                     Biodentine: All teeth (9/9) showed a complete bridge formation at 8 wks.\                                                                                                                                                                                                                                                                                                                      (18--32 years old patients)
                                                                                                                                                                             Pro-Root MTA (W-MTA; Dentsply-Sirona)                                                                                                                                   W-MTA: 5/9 teeth showed a complete bridge at 8 wks. 4/9 teeth showed an incomplete bridge at 8 wks.                                                                                                                                                                                                                                                                                            

  Jalan AL et al. (2017) \[[@B107-materials-13-02670]\]            RCT          Sterile cotton pellets + sterile saline                                                      Calcium-hydroxide cement (Dycal; Dentsply-Sirona)\                                                                No                             45 days                Dycal: 1/20 teeth showed no bridge formation. 4/20 teeth showed a complete bridge.\                                                                                                                     45 days                                                                                                                                                                                40 premolars (15--25 years old)
                                                                                                                                                                             Biodentine (Biodentine; Septodont)                                                                                                                                      Biodentine: all teeth showed bridge formation. 16/20 teeth complete bridge.                                                                                                                                                                                                                                                                                                                    

  Mehrvarzfar P et al. (2018) \[[@B108-materials-13-02670]\]       RCT          Sterile cotton pellets + sterile saline                                                      White Pro-Root MTA (W-MTA; Dentsply-Sirona)\                                                                      No                             6 weeks                W-MTA: 11/11 complete bridge was present in all specimens at 6 wk.\                                                                                                                                     6 weeks!                                                                                                                                                                               26 molars\
                                                                                                                                                                             W-MTA + Treated Dentin Matrix (W-MTA/TDM; Dentsply-Sirona)                                                                                                              W-MTA/TDM: 11/11 complete bridge was present in all specimens at 6 wks.                                                                                                                                                                                                                                                                                                                        (15--31 years old patients)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

materials-13-02670-t005_Table 5

###### 

Relative risks (95% CIs) and certainty in the evidence for pulp inflammation at day 30 after direct pulp-capping treatment on human pulp tissue.

  Comparison                                                               Direct Comparison          Indirect Comparison                              
  ------------------------------------------------------------------------ -------------------------- --------------------- -------------------------- ---------------
  Pro-Root MTA vs. calcium-hydroxide (CH) powder                           No studies available       Not available         No studies available ^1^   Not available
  Pro-Root MTA vs. CH cements (Dycal, Life, Calcipast, ...)                0.29 \[0.01, 5.79\]        VERY LOW ^2\ b^       0.39 \[0.04, 3.47\]        LOW ^a^
  MTA-like cements (Pro-Root MTA, Angelus MTA, ...) vs. CH powder          3.00 \[0.14, 65.90\] ^3^   VERY LOW ^3\ b^       2.67 \[0.29, 24.24\]       LOW ^a^
  MTA-like cements vs. CH cements                                          0.29 \[0.01, 5.79\]        VERY LOW ^b^          0.87 \[0.16, 4.71\]        LOW ^a^
  MTA-like cements vs. ALL CH-based materials (CH cements + powder)        0.93 \[0.15, 5.79\]        LOW                   1.17 \[0.26, 5.26\]        LOW ^a^
  CH cements vs. CH powder                                                 No studies available       Not available         5.41 \[0.27, 108.93\]      LOW ^a^
  Calcium-silicate cements (Biodentine, iRoot, ...) vs. MTA-like cements   No studies available ^4^   Not available         No studies available ^4^   Not available
  Resin-based vs. resin-free materials                                     2.41 \[0.48, 12.03\]       VERY LOW ^b^          1.33 \[0.44, 4.04\]        MODERATE ^a^

^1^ 11 studies available for indirect comparison between Pro-Root MTA (3/11 studies) vs. CH powder (8/11 studies). However, all of them retrieved 0 events (no severe inflammation or necrosis/abscess formation reported). Therefore, quantitative analysis is not possible. ^2^ Only 2 studies available for direct comparison between Pro-Root MTA vs. CH cements \[[@B53-materials-13-02670],[@B100-materials-13-02670]\]. ^3^ Only 1 study available for direct comparison between MTA-like cements vs. CH powder \[[@B52-materials-13-02670]\]. ^4^ No studies available evaluating inflammation of calcium-silicate cements (Biodentine, iRoot, ...) at 30 days or before. ^a^ Level of the evidence downgraded one level due to high risk of bias in all studies and due to imprecision as very few studies are available with very few events. ^b^ Level of the evidence very low due to high risk of bias in all studies and due to imprecision as very few studies are available with very few events.

materials-13-02670-t006_Table 6

###### 

Relative risks (95% CIs) and certainty in the evidence for pulp inflammation at day 15 after direct pulp-capping treatment on human pulp tissue.

  Comparison                                                                Direct Comparison          Indirect Comparison                              
  ------------------------------------------------------------------------- -------------------------- --------------------- -------------------------- -------------------
  Pro-Root MTA vs. calcium-hydroxide (CH) powder                            No studies available ^1^   Not available ^1^     No studies available ^1^   Not available ^1^
  Pro-Root MTA vs. CH cements (Dycal, Life, Calcipast, ...)                 Not available ^2^          Not available         0.54 \[0.02, 15.30\]       VERY LOW ^a^
  MTA-like cements (Pro-Root MTA, Angelus MTA, ...) vs. CH powder           No studies available ^3^   Not available         No studies available ^3^   Not available ^3^
  MTA-like cements vs. CH cements                                           0.33 \[0.02, 6.65\] ^3^    VERY LOW ^a^          Not available ^3^          VERY LOW ^a^
  MTA-like cements vs. ALL CH-based materials (CH cements + powder)         0.33 \[0.02, 6.65\] ^3^    VERY LOW ^a^          Not available ^3^          VERY LOW ^a^
  CH cements vs. CH powder                                                  No studies available       Not available         No studies available ^4^   Not available
  Calcium-silicate cements (Biodentine, iRoot, \...) vs. MTA-like cements   No studies available ^5^   Not available         No studies available ^5^   Not available
  Resin-based vs. resin-free materials                                      No studies available ^6^   Not available         No studies available ^6^   Not available

^1^ Only one study available for Pro-Root MTA (none for CH powder) \[[@B103-materials-13-02670]\]. ^2^ One study for direct comparison between Pro-Root MTA and CH cements (Life, Dycal, Calcipast, etc.) at day 15. However, it gave 0 events (no severe inflammation or necrosis/abscess formation reported). Therefore, quantitative analysis was not possible. ^3^ Only two studies available for MTA-like cements (both of them direct comparison against CH cements, none for CH powder) \[[@B89-materials-13-02670],[@B103-materials-13-02670]\]. ^4^ Only two studies available, both for CH cements \[[@B89-materials-13-02670],[@B103-materials-13-02670]\]. ^5^ No studies available evaluating inflammation of calcium-silicate cements (Biodentine, iRoot, etc.) at 30 days or before. ^6^ No studies available evaluating inflammation of resin-based materials at 15 days. ^a^ Level of the evidence very low due to high risk of bias in all studies and due to imprecision as very few studies are available with very few events.

materials-13-02670-t007_Table 7

###### 

Relative risks (95% CIs) and certainty in the evidence for pulp inflammation up to day 7 after direct pulp-capping treatment on human pulp tissue.

  Comparison                                                                Direct Comparison          Indirect Comparison                              
  ------------------------------------------------------------------------- -------------------------- --------------------- -------------------------- -------------------
  Pro-Root MTA vs. calcium hydroxide powder                                 No studies available       Not available         Not available ^1^          Not available ^1^
  Pro-Root MTA vs. CH cements (Dycal, Life, Calcipast, ...)                 0.24 \[0.01, 4.72\] ^2^    VERY LOW              0.34 \[0.02, 6.17\]        VERY LOW ^b^
  MTA-like cements (Pro-Root MTA, Angelus MTA, ...) vs. CH powder           No studies available       Not available         Not available ^3^          Not available ^3^
  MTA-like cements vs. CH cements                                           0.24 \[0.01, 4.72\] ^2^    VERY LOW ^2^          0.34 \[0.02, 6.17\]        VERY LOW ^b^
  MTA-like cements vs. ALL CH-based materials (CH cements + powder)         0.24 \[0.01, 4.72\] ^2^    VERY LOW ^2^          1.37 \[0.07, 25.71\]       VERY LOW ^2^
  CH cements vs. CH powder                                                  No studies available       Not available         15.42 \[0.79, 299.22\]     LOW ^a^
  Calcium-silicate cements (Biodentine, iRoot, \...) vs. MTA-like cements   No studies available ^4^   Not available         No studies available ^4^   Not available
  Resin-based vs. resin-free materials                                      0.84 \[0.12, 5.74\]        VERY LOW ^b^          0.84 \[0.12, 5.74\] ^5^    VERY LOW ^b^

^1^ Six studies available for indirect comparison (one Pro-Root MTA and five for CH powder); however, all of them retrieved 0 events (no severe inflammation or necrosis/abscess formation reported). Therefore, quantitative analysis was not possible. ^2^ Only one study for Pro-Root MTA \[[@B100-materials-13-02670]\]. ^3^ 6 studies available for indirect comparison (1 MTA-like cements and five for CH powder); however, all of them retrieved 0 events (no severe inflammation or necrosis/abscess formation reported). Therefore, quantitative analysis was not possible. ^4^ No studies available evaluating inflammation of calcium-silicate cements (Biodentine, iRoot, \...) at 30 days or before. ^5^ All events (severe inflammation or necrosis/abscess formation) are in studies with direct comparison. No events available for indirect comparison. ^a^ Level of the evidence downgraded one level due to high risk of bias in all studies and due to imprecision as very few studies are available with very few events. ^b^ Level of the evidence very low due to high risk of bias in all studies and due to imprecision as very few studies are available with very few events.

materials-13-02670-t008_Table 8

###### 

Relative risks (95% CIs) and certainty in the evidence for bridge formation after direct pulp-capping treatment on human pulp tissue.

  Comparison                                                                Direct Comparison              Indirect Comparison                                
  ------------------------------------------------------------------------- ------------------------------ --------------------- ---------------------------- ---------------
  Pro-Root MTA vs. Calcium-hydroxide (CH) powder                            No studies available           Not available         1.64 \[0.98, 2.77\]          MODERATE ^a^
  Pro-Root MTA vs. CH cements (Dycal, Life, Calcipast, ...)                 0.39 \[0.22, 0.67\] \*\*       HIGH                  0.56 \[0.42, 0.74\] \*\*\*   HIGH
  MTA-like cements (Pro-Root MTA, Angelus MTA, ...) vs. CH powder           1.50 \[0.66, 3.43\] ^1^        VERY LOW ^1^          2.02 \[1.21, 3.36\] \*\*     MODERATE ^a^
  MTA-like cements vs. CH cements                                           0.41 \[0.23, 0.73\] \*\*       HIGH                  0.59 \[0.45, 0.78\] \*\*\*   HIGH
  MTA-like cements vs. ALL CH-based materials (CH cements + powder)         0.66 \[0.47, 0.92\] \*         HIGH                  0.80 \[0.62, 1.03\]          HIGH
  CH cements vs. CH powder                                                  Not available                  Not available         3.23 \[2.00, 5.20\] \*\*\*   MODERATE ^a^
  Calcium-silicate cements (Biodentine, iRoot, \...) vs. MTA-like cements   0.84 \[0.43, 1.65\]            MODERATE ^a^          0.81 \[0.47, 1.40\]          MODERATE ^a^
  Biodentine vs. Pro-Root MTA                                               0.50 \[0.04, 6.43\]            VERY LOW ^3\ b^       0.86 \[0.36, 2.02\]          LOW ^b^
  Calcium-silicate cements vs. CH powder                                    Not available                  Not available         1.80 \[0.95, 3.40\]          LOW ^a\ b^
  Calcium-silicate cements vs. CH cements                                   0.25 \[0.10, 0.62\] \*\* ^2^   VERY LOW ^2^          0.47 \[0.15, 1.44\]          LOW ^a\ b^
  Resin-based vs. resin-free materials                                      3.69 \[2.23, 6.12\] \*\*\*     HIGH ^a^              Not performed ^4^            Not performed

^1^ Only one study available for direct comparison between MTA-like cements vs. CH powder \[[@B52-materials-13-02670]\]. ^2^ Only 1 study available for direct comparison between calcium-silicate cements vs. CH cements \[[@B107-materials-13-02670]\]. ^3^ Only two studies available for direct comparison between Biodentine vs. Pro-Root MTA \[[@B104-materials-13-02670],[@B106-materials-13-02670]\]. ^4^ The direct comparison was strong enough (13 studies). ^a^ Level of the evidence downgraded one level due to high risk of bias in all studies. ^b^ Level of the evidence downgraded one level due to high risk of bias in all studies and imprecision. \* The result is statistically significant (*p* \< 0.05); \*\* The result is statistically significant ( *p* \<0.01); \*\*\* The result is statistically significant (*p* \< 0.001 or lower).

[^1]: These authors contributed equally to this work.
